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ABSTRACT 
 
Integration of Microvascular, Interstitial, and Lymphatic Function to Determine the 
Effect of Their Interaction on Interstitial Fluid Volume.  
(December 2008) 
Ranjeet Manohar Dongaonkar, B.E., Dr. Babasaheb Ambedkar Marathwada University; 
M.S., Texas A&M University 
Chair of Advisory Committee: Dr. Christopher M. Quick 
 
 Although the physics of interstitial fluid balance is relatively well understood, 
clinical options for the treatment of edema, the accumulation of fluid in the interstitium, 
are limited. Two related reasons for this failure can be identified. First, the processes 
involved in the transfer of fluid and proteins into the interstitium from the 
microvasculature, and their transfer out of the interstitium via the lymphatic system, are 
governed by complex equations that are not amenable to manipulation by physiologists. 
Second, the fundamental processes involved include complex anatomical structures that 
are not amenable to characterization by engineers. The dual tools of the batwing model 
and simplified mathematical modeling can be used to address the main objective: to 
integrate microvascular, interstitial, and lymphatic function to determine the effect of 
their interaction on interstitial fluid volume. In order to address this objective and the 
limitations of the current state of knowledge of the field, three specific aims were 
achieved. 1) Develop a simple, transparent, and general algebraic approach that predicts 
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interstitial fluid pressure, volume and protein concentration resulting from the interaction 
of microvascular, interstitial and lymphatic function. These algebraic solutions provide a 
novel characterization of interstitial fluid pressure as a balance point between the two 
processes that determine interstitial inflow and outflow. 2) Develop a simple, algebraic 
formulation of Edemagenic Gain (the change in interstitial fluid volume resulting from 
changes in effective microvascular driving pressure) in terms of microvascular, 
interstitial and lymphatic structural parameters. By separating the structural parameters 
from functional variables, this novel approach indicates how these critical parameters 
interact to determine the tendency to form edema. 3) To expand the list of known 
interactions of microvascular, interstitial, and lymphatic functions to include the direct 
interaction of venular and lymphatic function. Venomotion was found not only to 
extrinsically pump lymph but also to mechanically trigger intrinsic lymphatic 
contractions. These three advances together represent a new direction in the field of 
interstitial fluid balance, and could only be possible by taking an interdisciplinary 
approach integrating physiology and engineering. 
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1. INTRODUCTION 
 
1.1 BACKGROUND 
Interstitial inflow: interstitial fluid pressure and protein concentration determine 
flow of microvascular fluid and proteins into the interstitium. The fluid filtration rate 
across a microvascular membrane, originally described by the Starling Hypothesis (139), 
is a result of an imbalance between two competing forces—hydrostatic and colloid 
osmotic pressures (95, 120). A decrease in interstitial fluid pressure increases the 
hydrostatic pressure gradient, driving the fluid into the interstitium. A decrease in 
interstitial protein concentration, however, increases the colloid osmotic pressure 
gradient, maintaining fluid in the microvasculature. The two structural parameters that 
modulate the effects of these forces are the microvascular filtration coefficient (Kf), 
characterizing the permeability to water, and the reflection coefficient (σ), characterizing 
the relative permeability to proteins. On the other hand, the protein transfer rate across 
microvascular membrane is a result of convection due to fluid filtration and diffusion 
due to a protein concentration gradient. A decrease in interstitial fluid pressure increases 
the fluid filtration rate, driving proteins into the interstitium. A decrease in interstitial 
protein concentration increases the protein concentration gradient, also driving proteins 
into the interstitium. The two structural parameters that modulate these two processes are 
the reflection coefficient (σ) and the product of microvascular protein permeability and 
the microvascular surface area (PS) (147). In transfer of both fluid and proteins,  
____________ 
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interstitial fluid pressure and protein concentration thus play significant roles. Perhaps 
the complexity of interstitial fluid and protein dynamics has masked the fact that inflow 
and outflow can have a significant effect on interstitial fluid pressure (Pi) and protein 
concentration (Ci) (5, 65, 142). Typically, the values of Pi and Ci are assumed constant, 
i.e., unaffected by changes in interstitial inflow (40).  
Interstitial outflow: interstitial fluid pressure determines flow of fluid and 
proteins out of the interstitium. The lymphatic system drains fluid and proteins from the 
interstitium. Characterizing the function of a single lymphatic vessel is complicated by 
the interplay of the axial pressure gradient, transmural pressure, and endothelial shear 
stress (7, 54, 55, 75, 106). Characterizing the function of an entire lymphatic system, 
however, is relatively simple, since the lymphatic system pressure-flow relationship can 
be linear over a large range of pressures (5, 22, 23). In a series of articles, Drake et al. 
successfully characterized the lymphatic pressure–flow relationship with two 
empirically-derived parameters—the effective lymphatic resistance (RL) and the 
effective pump pressure (Pp) (39, 42, 44, 91, 93). As interstitial fluid pressure increases, 
the resulting increase in axial pressure gradients and transmural pressures act in concert 
to increase lymph flow (75). A recent study related the values of RL and Pp to the 
mechanical properties of lymphatic vessels, including vessel contractility and 
contraction frequency (34). Although investigators have used Drake’s formulation to 
predict the interaction of one part of a lymphatic system with another (143), this 
powerful description has not yet been used to address lymphatic-microvascular 
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interaction. In fact, a significant number of studies neglect the effect of lymphatic 
function on interstitial fluid balance (40). 
Conservation of mass: edema is conventionally characterized as an imbalance of 
interstitial inflow and outflow. The process of interstitial fluid volume and protein 
regulation is typically characterized by invoking the principle of conservation of mass. 
The difference between interstitial inflow and outflow rates determines the rate of 
change in interstitial fluid volume and proteins. That is, when the inflow rate is greater 
than the outflow rate, the amounts of interstitial fluid and proteins increase. Conversely, 
when the outflow rate is greater than the inflow rate, the amounts of interstitial fluid and 
proteins decrease. The principle of conservation of mass is powerful, but limited. For 
instance, if only microvascular filtration is elevated experimentally, then gravimetric 
approaches can be used to ascribe changes in interstitial fluid volume to changes in 
microvascular permeability (40). However, measurement of interstitial fluid volume 
alone does not reveal whether microvascular filtration has increased or lymphatic 
function has decreased. In fact, once edema is established, inflow is equal to outflow, 
and no information is available to determine whether microvascular or lymphatic 
function has been compromised. Furthermore, the amount of microvascular filtration and 
lymph flow in steady-state is not directly related to interstitial fluid volume–edema can 
be associated with both high and low flows (34). Finally, because both conservation of 
mass and balance of forces are necessary to characterize mechanical systems from 
fundamental principles (51), characterization of edema as a mismatch of inflow and 
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outflow is theoretically incomplete. Taken together, conservation of mass is necessary, 
but not sufficient, to characterize interstitial fluid balance. 
Interstitial storage: interstitial compliance is conventionally believed to 
determine interstitial fluid pressure. The interstitium’s capacity to store fluid is a 
fundamental mechanical property characterized by the “interstitial compliance”, the 
slope of the interstitial fluid volume-pressure relationship (63, 131). Interstitial 
compliance is believed to play a fundamental role in interstitial fluid balance—it 
determines how much interstitial fluid pressure rises with an increase in interstitial fluid 
volume. Three related concepts follow. First, the extraordinarily high interstitial 
compliance reported for the lung may prevent complications arising from edema (63, 
140). In this case, interstitial fluid volume can significantly increase without a 
concomitant increase in interstitial fluid pressure, thus preventing alveolar flooding (63, 
140). Second, decreasing the effective interstitial compliance with compressive sleeves 
may reduce peripheral edema by raising interstitial fluid pressure (17, 23). In this case, 
reduction of interstitial fluid volume follows from diminished microvascular filtration 
and enhanced lymphatic drainage. Third, increasing interstitial compliance with 
pharmacological agents or focal injury may induce edema by decreasing interstitial fluid 
pressure (132). In this case, the lower interstitial fluid pressure draws fluid into the 
interstitium from the microvascular space. Inherent in all three concepts, a change in 
interstitial compliance is believed to alter the equilibrium interstitial fluid pressure. 
Venules and lymphatic microvessels modulate interstitial fluid volume. It is 
believed that lymphatic microvessels developmentally derive from venules (118, 138), 
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and they not only share similar structure, but also are often located within microns of 
each other (150). Venules function to moderate microvascular fluid pressure, and thus 
the driving pressure for transmicrovascular flux (27, 28, 59, 78). Lymphatic 
microvessels, however, play a central role in regulating not only interstitial fluid volume 
but also the turnover of interstitial proteins (69, 144). Lymph, interstitial fluid that has 
entered the initial lymphatics, is transported by intrinsic as well as extrinsic mechanisms 
via a system of converging conducting lymphatic vessels to the lymph nodes and then to 
the great veins of the neck. Since lymph flow is inhibited by increases in central venous 
pressure (i.e., the lymphatic outlet pressure), venous and lymphatic functions are coupled 
at their outlets as well as at their inlets (36, 91). Although venules typically can be found 
within microns of parallel lymphatic microvessels (150) and both play a critical role in 
regulating the local environment of the interstitium, venular and lymphatic 
microvascular functions are conventionally described as indirectly coupled. 
Lymph is actively propelled by extrinsic mechanical compression. 
Lymphangions, the segments of lymphatic vessels between two unidirectional valves, 
provide the structure that allows lymph to be actively propelled from the low-pressure 
interstitial space to the higher-pressure veins (144, 167). Although it is recognized that 
cyclical contraction of muscular lymphatic vessels can propel lymph, external 
compression is the only means of propulsion in the intestinal wall, skeletal muscle, heart, 
and lung, where lymphatic microvessels are devoid of lymphatic smooth muscle (136). 
In these organs, lymph formation and propulsion depends solely on periodic extrinsic 
expansion and compression of lymphangions by surrounding tissues (96, 105). Schmid-
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Schönbein et al., suggested that in addition to contractions of the surrounding muscle, 
arteriolar vasomotion may also extrinsically propel lymph from initial lymphatic vessels 
in skeletal muscle (135, 137). In organs such as skin, which is not surrounded by 
periodically contracting tissues, it is believed that intrinsic pumping is necessary to 
propel lymph. 
Mechanical stimuli modulate intrinsic pumping of the lymphatic vessel. 
Contraction of lymphatic muscle, leading to the intrinsic pumping of lymph, is 
modulated by mechanical factors. First, tension in the filaments tethering lymphangions 
to the interstitium can passively enhance filling from upstream lymphangions or from 
the surrounding interstitium (20). Second, stretch of lymphatic muscle is known to 
enhance pacemaker activity and thus increase the frequency and strength of 
lymphangion contraction (7, 75, 106). This mechanism has been proposed to increase 
lymphangion pumping with increased tissue hydration (7). Furthermore, a rapid stretch 
is known to trigger an intrinsic contraction of vascular smooth muscle (116), which is 
one mechanism that can cause a lymphangion to contract after being filled by an 
upstream lymphangion. Each mechanism allows a lymphatic vessel to respond to the 
mechanical forces in its immediate environment. The sensitivity of lymphatic function to 
common anesthetics, trauma resulting from exteriorizing lymphatic beds, and even 
contrast agents used for visualization (2, 26, 77, 107), have limited the investigation of 
the role of mechanical forces on lymphangion function in vivo. 
There are multiple explanations for histamine-induced pulmonary edema. The 
difficulty in ascribing changes in interstitial fluid volume to a particular volume-
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regulating phenomenon is put in bold relief by the example of histamine. Infusion of 
histamine induces edema within minutes (88, 111, 124). Some reports ascribe this effect 
to increased transmicrovascular fluid flux due to increased permeability or vascular 
surface area (11, 88, 108, 115, 124). Lymph flow is reported to increase with histamine 
infusion (3, 11, 19, 33, 46, 73, 108, 115, 133) either by increased contraction rate (47) or 
by increased strength of contraction (76, 133, 146). However, inhibition of lymph flow 
with intravenous infusion of histamine at high concentrations (> 5μM) (47, 127) has also 
been reported, and thus the lymphatic system may play a role. Yet another mechanism 
for edema formation has been postulated that does not require changes in permeability or 
lymphatic function. Histamine has been reported to increase interstitial compliance (3, 
130). That is, given the same interstitial fluid pressure, the interstitium can accommodate 
a much larger volume of fluid. The resulting change in compliance alone is capable of 
producing edema in skin and skeletal muscle (130, 160). This example illustrates a 
common difficulty in edema research—multiple mechanisms can lead to edema, and 
current analytical tools are not able to determine their relative contributions. 
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2. DISSERTATION OBJECTIVES 
 
Analysis of the literature presented in Section 1 provides the insight that guides 
the focus of this Dissertation. First, fluid volume and pressure are typically characterized 
as a function of either microvascular (11, 88, 108, 115, 124), lymphatic (47, 127), or 
interstitial (3, 130, 160) function. Although microvascular function has been 
characterized algebraically, the lack of a simple description of lymphatic function has 
hindered the integration of these three functions. One such analytical description by 
Drake et al. (38) has yet to be used in such formulations. Although it is evident that 
interstitial fluid pressure and protein concentration play critical role, the relative 
contributions of lymphatic function and microvascular function to interstitial fluid 
volume and pressure is not well understood. This has led to a number of complications, 
including ascribing changes in interstitial fluid volume solely to either changes in 
microvascular function (characterized by the filtration coefficient) (11, 88, 108, 115, 
124), changes in interstitial function (characterized by interstitial tissue compliance) (3, 
130, 160) or lymphatic function (characterized by lymphatic pump function) (47, 127). 
The particular function that an investigator identifies as a cause for an observed change 
in interstitial fluid volume typically depends on the starting set of assumptions or 
professional focus of the investigator. It is necessary to integrate these three functions to 
explore how the whole of interstitial fluid regulation becomes more than the sum of its 
constituent parts. 
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Second, the sensitivity of tissues to an edemagenic challenge is as important as 
the degree of edema. Edema can be both a cause and an effect (14, 24, 125) of major 
morbidity such as cardiac, renal and pulmonary failure. The techniques used to 
determine the degree of edema, however, have limited prognostic potential. For instance, 
different inflammatory agents such as histamine and endotoxin can result in similar 
degrees of edema, although edema secondary to endotoxin is more likely to worsen with 
increased microvascular pressure (1, 92). Despite a focus on anti-edema mechanisms, 
investigators have neglected to address this sensitivity of edema formation to 
edemagenic challenges. Though the concept of a “gain” has been used to characterize 
whole-body fluid balance (64), it has yet to be applied to interstitial fluid balance. The 
potential exists to bridge the gap between basic physiology and clinical practice, since 
the complexity of interstitial fluid balance results from three relatively simple 
phenomena—interstitial inflow, interstitial inflow, and interstitial fluid storage. 
However, it is first necessary to develop a simple algebraic formula that explicitly 
illustrates how the critical structural parameters interact to regulate interstitial volume. 
Third, although a direct interaction has been experimentally demonstrated 
between microvascular and interstitial function (48, 56, 104, 141) or interstitial and 
lymphatic function (21, 145, 168), it has been assumed that microvascular and lymphatic 
function are indirectly coupled (36, 91). The role of vasomotion, in particular, has been 
neglected. Arterioles as well as venules are observed to exhibit vasomotion, active 
spontaneous contractions. Venomotion, i.e., venular vasomotion, involves a large change 
in diameter. As a result, tissue surrounding venules adjacent to lymphatic vessels 
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experiences compression and expansion during venular dilation and contraction. Since 
lymphatic microvessels can be found in close proximity of venules exhibiting 
venomotion, venules may directly affect the mechanical environment of lymphatic 
microvessels through venomotion. Although the role of arteriolar vasomotion in 
extrinsic propulsion of lymph in skeletal muscle has been characterized, the sensitivity 
of venomotion as well as lymphatic function to common anesthetics and trauma may 
have limited the characterization of venular-lymphatic interaction. There is a critical 
need for an animal model that does not require anesthetics or surgical exteriorization of 
the microvasculature to study the possible direct interaction of venular and lymphatic 
function. 
Two major reasons can be identified why these three problems have not yet been 
addressed in the literature. First, few investigators have applied simplified mathematical 
modeling to integrate interstitial fluid volume and protein regulation. Second, there is a 
critical lack of animal models appropriate to test hypotheses. 
The individual processes involved in interstitial fluid volume and protein 
regulation are simple. However, the integration of these simple processes has yielded 
complex results that have obscured elucidation of their interaction. The presence of the 
negative feedback and the derivative introduced in the equation characterizing interstitial 
fluid balance, in particular, have limited to tools available for conventional mathematical 
modeling. To deal with these complications, most of investigators have relied on 
complex mathematical models that require numerical solutions. However, numerical 
approaches have a number of inherent limitations; the most critical of which is the lack 
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of general solution. Numerical approaches result in specific solutions valid only for 
specific known values of parameters used in the simulation. Second, separate plots are 
needed to determine the effect of any one of a long list of parameters and variables: 
microvascular pressure, plasma colloid osmotic pressure, water permeability, interstitial 
compliance, effective lymphatic resistance, venous pressure. Furthermore, the inability 
to view the effect of more than one parameter on interstitial fluid volume and pressure 
makes it impossible to grasp the complex interaction between interstitial inflow and 
outflow. The small error incurred when making simplifying assumptions to arrive at an 
algebraic solution (explicitly relating system function to its structure) can be worth the 
insight gained with a simple formula. 
Venomotion was first observed in the bat wing over a hundred and fifty years 
ago (81), in part, because the thin translucent wing made it possible to study the intact 
microvasculature noninvasively without the confounding effects of surgery, anesthesia, 
or contrast agents. Bat wing preparations have since been used to make fundamental 
advancements in the understanding of vascular innervation (155), the myogenic response 
(16, 31), shear-induced dilation (29, 152), arteriolar and venular vasomotion (15, 148, 
154), and capillary recruitment (153). Most vascular responses have been shown to be 
similar to more common animal models such as the hamster cheek pouch, rat mesentery, 
and cremaster muscle, although bat wing responses are often more robust (29, 31). Since 
venomotion is diminished by common anesthetics (26), the unanesthetized bat wing 
model is particularly advantageous for studying venomotion. 
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The dual tools of the batwing model and simplified mathematical modeling can 
be used to address the main objective: to integrate microvascular, interstitial, and 
lymphatic function to determine the effect of their interaction on interstitial fluid volume. 
In order to address this objective and the limitations of the current state of knowledge of 
the field, three specific aims must be achieved. 1) To develop a simple, transparent, and 
general algebraic approach that predicts interstitial fluid pressure, volume and protein 
concentration resulting from the interaction of microvascular, interstitial and lymphatic 
function. These algebraic solutions will provide a novel characterization of interstitial 
fluid pressure as a balance point between the two processes that determine interstitial 
inflow and outflow. 2) Develop a simple, algebraic formulation of Edemagenic Gain (the 
change in interstitial fluid volume resulting from changes in effective microvascular 
driving pressure) in terms of microvascular, interstitial and lymphatic structural 
parameters. By separating the structural parameters from functional variables, this novel 
approach will indicate how these critical parameters interact to determine the tendency 
to form edema. 3) To expand the list of known interactions of microvascular, interstitial, 
and lymphatic functions to include the direct interaction of venular and lymphatic 
function. It is hypothesized that venomotion not only acts to extrinsically pump lymph 
but also to mechanically trigger intrinsic lymphatic contractions. The following sections 
will address each of these specific aims. 
Section 3: By integrating lymphatic function into the set of standard fluid balance 
equations, interstitial fluid volume and protein regulation will be formulated 
algebraically in terms of parameters characterizing microvascular, interstitial, and 
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lymphatic function. General algebraic solutions for steady-state interstitial fluid pressure 
and protein concentration will be derived using this formulation. This approach will 
result in the novel finding that interstitial compliance does not affect steady-state 
interstitial pressure. 
Section 4: A simple solution to the standard fluid balance equations will be 
developed by making critical simplifying assumptions. Reformulation of the classical 
equations governing fluid balance as transfer functions will yield a novel index: the 
Edemagenic Gain. This approach will result in the novel finding that there are two types 
of edema: multivariate edema and compliance-dominated edema. 
Section 5: The Pallid bat wing model will be used to simultaneously record 
diameters of venules and adjacent lymphatic microvessels and evaluate the temporal 
relation between their contractions. Two possible mechanisms for interaction will be 
explored: direct compression of lymphatic vessels by the expanding venule during 
venomotion, and the potential for movement of an adjacent venule to mechanically 
trigger lymphatic contraction. This approach will result in the novel finding that with 
venular-lymphatic coordination; extrinsic and intrinsic lymph pumping mechanisms may 
not only coexist, but also are coordinated. 
Section 6: Results from Sections 3-5 will be discussed, and implications to the 
new understanding of interstitial fluid balance will be identified. 
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3. INTEGRATING MICROVASCULAR, INTERSTITIAL, AND LYMPHATIC 
FUNCTION WITH A BALANCE POINT CHARACTERIZATION OF 
INTERSTITIAL FLUID VOLUME AND PROTEIN REGULATION 
 
3.1 METHODS  
Interstitial inflow of fluid. The Starling-Landis Equation (Eq. 3.1) characterizes 
the fluid filtration rate (JV) across microvascular membrane into the interstitium (95, 
120). The transmicrovascular fluid flow rate is determined by the microvascular 
filtration coefficient (Kf) in response to effective microvascular driving pressure 
resulting from hydrostatic and colloid osmotic pressure gradients. The difference 
between microvascular (Pc) and interstitial (Pi) hydrostatic pressures tends to force fluid 
into the interstitium. The value of Kf depends on microvascular surface area and 
permeability to water. The difference between microvascular (Πc) and interstitial (Πi) 
colloid osmotic pressures tends to draw fluid in the opposite direction, from the 
interstitium into the microvessels. The reflection coefficient (σ) characterizes the relative 
permeability of the microvasculature to plasma proteins (having a value between 0 and 
1), and thus modulates the contribution of colloid osmotic pressure to effective 
microvascular driving pressure. 
[ ]( ) ( )V f c i c iJ K P P σ= − − Π − Π  (3.1)
To be consistent with rest of the analysis, Starling-Landis Equation is formulated 
in terms of plasma (Cc) and interstitial protein (Ci) concentration given by Eq. 3.2 and 
will be used henceforth. 
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[ ]( ) ( )V f c i c iJ K P P C Cασ= − − −  (3.2)
When concentration is in moles/kg, α can be estimated by R·T, where R is the ideal gas 
constant and T is absolute temperature (151). When concentration is in mg/ml, an 
experimentally derived value for α is used (70, 71). Consistent with previous work (34), 
Pc, Pi, Cc, and Ci are considered variables, and Kf and σ are considered structural 
parameters. 
Interstitial inflow of proteins. The microvascular protein extravasation rate (JsV) 
(i.e., the interstitial inflow of proteins) is characterized using the linear Taylor-Granger 
Equation (Eq. 3.3) (6, 147). In this formulation, protein flux across microvascular 
membrane is determined by convective as well as diffusive processes. The 
microvascular fluid filtration rate (JV) drives the convective transfer of proteins, and is 
modified by Cc and σ. The protein concentration gradient across microvascular 
membrane (Cc-Ci) drives protein diffusion, and is modified by the microvascular protein 
permeability-surface area product (PS). 
(1 ) ( )sV V c c iJ J C C C PSσ= − + −  (3.3)
Although, this formulation is based on an approximation proposed by Kedem et al. (84) 
that treats diffusion and convection as independent processes, comparison with other 
formulations suggested that the Taylor-Granger formulation better approximates the 
well-accepted nonlinear Patlak-Hoffman (123) formulation (Eq. C2) (see Appendix C).  
Interstitial outflow of fluid. The Drake-Laine Equation (Eq. 3.4) characterizes 
lymphatic function by relating lymph flow rate (JL) to an effective lymphatic driving 
pressure (38). Since lymphatic outlet pressure (Pout) is typically greater than interstitial 
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fluid pressure (Pi), the difference in Pi and Pout tends to retard lymph flow. The value of 
(Pi+Pp) represents the lymphatic driving pressure and is composed of interstitial 
hydrostatic pressure and lymphatic pumping pressure (Pp). The effective lymphatic 
resistance (RL) is the slope of the relationship between effective lymphatic driving 
pressure (Pi+Pp-Pout) and the resulting lymph flow. 
( )i p out
L
L
P P P
J
R
+ −=  (3.4)
In this formulation Pp and RL are empirically-derived parameters used to describe the 
lymphatic pressure-flow relationship (38), and are not necessarily equivalent to pressure 
developed by lymphatic vessel contraction or resistance to lymph flow. Recently, Pp and 
RL were related to lymphatic contractility and contraction frequency (34). 
Interstitial outflow of proteins. Although lymph protein concentration can deviate 
from Ci, for simplicity, it is assumed in this work that they are equal. That is, with no 
protein concentration gradient across lymphatic membrane, the interstitial outflow rate 
of proteins is determined by a convective process only. Using the Drake-Laine Equation 
(Eq. 3.4) to characterize the lymphatic fluid drainage rate (JL) driving convection, the 
rate of lymphatic drainage of interstitial proteins (JsL) takes on a simple form. 
( )i p out
sL i L i
L
P P P
J C J C
R
+ −= =  (3.5)
Characterizing steady-state conditions. A steady-state condition is reached when 
the rates of interstitial inflow and outflow of both fluid and proteins are balanced. At 
steady-state, interstitial fluid volume and protein assume constant values (Eq. 3.6). 
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V LJ J=  (3.6a)
sV sLJ J=        (3.6b)
Characterizing interstitial storage. The interstitium’s capacity to store fluid is a 
fundamental mechanical property characterized by the “interstitial compliance”, the 
slope of the interstitial fluid volume-pressure relationship (63, 131). The relationship 
between interstitial fluid pressure and volume can be highly nonlinear (63, 131). 
Typically, under normal conditions, interstitial fluid pressure is sensitive to changes in 
interstitial fluid volume (i.e., C is small). With overhydration, the compliance can 
become much larger, and the sensitivity of interstitial fluid pressure to interstitial fluid 
volume is lost (63). To capture this behavior, the interstitial fluid pressure-volume 
relationship has been approximated to be “piecewise linear,” a commonly used 
technique to deal with the effect of hydration on interstitial compliance (12, 22, 70). 
Interstitial storage of proteins is characterized by the ratio of total interstitial protein (Q) 
and interstitial fluid volume (IFV).   
0
i
IFV VP
C
−=  (3.7a)
i
QC
IFV
=  (3.7b) 
In this case, V0 is the intercept of the interstitial fluid volume-pressure relationship, C is 
the interstitial compliance.  
Control theory approach. The individual subsystems that govern interstitial fluid 
volume and protein are relatively simple (Eqs. 3.2-3.7). However, their interaction can 
be complex, given that there is inherent feedback in the system. To simplify, the 
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regulation of interstitial fluid volume and protein are analyzed using the transfer function 
concept of classical control theory, commonly used to characterize systems with 
feedback (49). For analysis purposes, the sub-systems are assumed to be linear and time-
invariant, meaning that they are characterized by structural parameters such as Kf, σ, RL, 
and Pp, which are assumed to be constant over the period of interest. Variables such as 
Pc, Pi, Cc, Ci, and V are treated as either inputs or outputs to each subsystem. Block 
diagrams are then constructed to represent the transfer functions created from Eqs. 3.2-
3.7. 
 
3.2 RESULTS 
Graphical representation of steady-state. The steady-state values of Pi and Ci can 
be represented graphically using a standard balance-point approach (62, 67). For 
illustration purposes, Fig. A-1A represents the interstitial fluid flow balance point. To 
construct it, first the relationship of Pi and JV (Eq. 3.2) is plotted. Assuming that 
interstitial protein concentration is in equilibrium, this relationship is linear, with a slope 
of -Kf and an intercept of Pc-ασ(Cc-Ci). Then the relationship of Pi and JL (Eq. 3.4) is 
plotted. This relationship is also linear, and has a slope of RL and intercept of Pout -Pp.  
Because JV =JL at steady-state, these lines are placed on the same graph. The equilibrium 
between Jv and JL is represented by the intersection, which yields the value of Pi in 
equilibrium. This equilibrium point is the interstitial fluid flow balance point.  A similar 
process is used to graphically illustrate the interstitial protein flow balance point in Fig. 
A-1B, constructed from Eqs. 3.3 and 3.5. 
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Algebraic solutions characterizing equilibriums. As steady-state is reached, 
interstitial inflow rates are balanced with outflow rates, leading to constant interstitial 
fluid volume and protein content.  To algebraically represent the interstitial fluid and 
protein balance points, Eqs. 3.2-3.6 are solved simultaneously, assuming steady-state 
conditions represented by Eq. 3.5 (Eq. 3.8).  
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(3.8b)
Notably, interstitial compliance (C), does not appear in these equations, indicating a non-
intuitive result that interstitial compliance has no affect on interstitial fluid pressure (Eq. 
3.8a). Substituting Eqs. 3.8a and 3.8b into Eqs. 3.4 and 3.5 yield equilibrium lymphatic 
outflow of fluid and protein. 
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Block-diagram representation of interstitial fluid volume and protein regulation. 
Figure A-2A illustrates the block-diagram representations of interstitial fluid volume 
regulation under steady-state conditions. Parts I and II represent microvascular driving 
pressure and lymphatic effective pumping pressure. A combination of KfRL arises in 
simple transfer functions that modulate these driving pressures. Pi arises as a sum of the 
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two modified pressures I and II (corresponding to the left and right terms in Eq. 3.8a). 
Notably, IFV is revealed to be an output of a transfer function consisting of a parameter 
C characterizing the interstitial compliance, and results from the input Pi.  The value of 
Pi itself is not affected by the value of C.  Similarly, Fig. A-2B illustrates the block-
diagram representation of interstitial protein regulation under steady-state conditions.  
Estimation of Pi and Ci at steady-state. The algebraic formulas represented by 
Eq. 3.8 were used to predict steady-state values of Pi and Ci in different organs. The 
resulting estimates of Pi and Ci were then compared with previously reported values of 
Pi and Ci derived experimentally (45, 74, 80, 94, 97, 160). Values of parameters (Kf, σ, 
RL, Pp) were collected from various publications that used similar experimental models 
and conditions. Table B-1A illustrates the comparison between interstitial fluid pressure 
and protein concentration estimates with experimental measurements. The effect of a 
change in parameters Kf and σ was evaluated in the case of dog lung. Minimum and 
maximum values of these parameters reported in the literature were used to determine 
the range of resulting values of Pi and Ci (Table B-1B and B-1C). As Kf increased from 
the minimum to maximum reported values (0.07 to 0.11), Pi increased from -2.2 to -1.3 
mmHg and Ci decreased from 31 to 30.7 mg/ml (Table B-1B). Similarly, an increase in σ 
from the minimum to maximum reported values (0.48 to 0.89) resulted in a decrease in 
Pi from   -0.2 to -6.7 mmHg and a decrease in Ci from 36.6 to 22.9 mg/ml (Table B-1C). 
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4. EDEMAGENIC GAIN AND INTERSTITIAL FLUID VOLUME REGULATION* 
 
4.1 METHODS: THEORY  
The Starling-Landis Equation (Eq. 3.1) used to characterize microvascular fluid 
filtration and the Drake-Laine Model (Eq. 3.4) used to characterize lymphatic function 
are explained in previous section. In brief, the Starling-Landis equation relates 
microvascular fluid filtration rate (JV) to effective microvascular driving pressure 
determined by microvascular (Pc) and interstitial (Pi) hydrostatic pressures and 
microvascular (Πc) and interstitial (Πi) colloid osmotic pressures. The reflection 
coefficient (σ) and microvascular filtration coefficient (Kf) modulate this relationship. 
The Drake-Laine Model (Eq. 3.4) relates lymph flow rate (JL) to an effective lymphatic 
driving pressure (38) determined by interstitial hydrostatic pressure (Pi), lymphatic 
pumping pressure (Pp), and lymphatic  outlet pressure (Pout). The effective lymphatic 
resistance (RL) is the slope of the relationship between effective lymphatic driving 
pressure and the resulting lymph flow.  
The nonlinear relationship of interstitial hydrostatic pressure and interstitial fluid 
volume is assumed to be simple piecewise linear relationship (Eq. 4.1). The slope of this 
relationship is the reciprocal of interstitial compliance (C),  
 
 
 
____________ 
* Reprinted with permission from “Edemagenic gain and interstitial fluid volume 
regulation” by R. M. Dongaonkar, C. M. Quick, R. H. Stewart, R. E. Drake, C. S. Cox, 
Jr., and G. A. Laine, 2008. Am J Physiol Regul Integr Comp Physiol 294: R651-R659, 
Copyright [2008] by The American Physiological Society.  
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1
i oP P VC
= + ⋅  (4.1)
where Po is an empirical constant.  
Interstitial fluid inflow rate (Eq. 3.1) and interstitial fluid outflow rate (Eq. 3.4) 
are both functions of interstitial fluid pressure, and thus, interstitial fluid volume (Eq. 
4.1). Assuming conservation of mass, the rate of change of interstitial fluid volume (i.e., 
dV/dt) is equal to the difference in rates of interstitial inflow and outflow of fluid.  
V L
dV J J
dt
= −  (4.2)
With known values of parameters (Pp, C, RL, Kf) and inlet and outlet pressures 
(Pc-σ ·Πc and Pout), Eqs. 3.1, 3.4, 4.1, and 4.2 can be solved simultaneously for four 
unknown variables (JV, JL, Pi, and V) (see Appendix D). In the present approach, 
variations in interstitial colloid osmotic pressure (Πi) are neglected. Previously published 
reports were reviewed to characterize the possible range of parameter values and 
summarized in Table B-2. 
 
4.2 METHODS: EXPERIMENT  
The experimental preparation has been described previously (53). Experiments 
were conducted in accordance with protocols approved by the University of Texas 
Medical School Animal Welfare Committee. Briefly, sheep (n = 20) were anesthetized 
with halothane. Using sterile technique, polyethylene catheters were placed into the 
pulmonary artery and left atrium through a left thoracotomy. A 30cc Foley balloon 
catheter was introduced into the left atrium, and fluid filled catheters into the right 
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atrium via either the azygous vein or the left femoral vein. The chest was closed, and the 
sheep were allowed to recover for approximately one week before the acute experiments. 
Postoperative antibiotics and analgesics were administered by veterinarians as clinically 
indicated.  
This preparation allowed the measurement of pulmonary arterial (PAP) and left 
atrial pressures (LAP). A pressure control system was used to regulate the size of the left 
atrial balloon and control LAP in a subgroup of sheep (n = 5) (53). Pulmonary 
microvascular pressure (Pc) was estimated as the average of PAP and LAP (53). Solid-
state pressure transducers, amplifiers and a chart recorder were used to record all 
pressures. The olecranon was chosen as the zero pressure reference level because it is 
near the level of the left atrium and was easily identified (53). Plasma colloid osmotic 
pressure (Πc) was measured with a membrane osmometer. Sheep were euthanized after a 
3 h period and the extravascular fluid weight/blood free dry weight ratio (EVF) was 
determined utilizing a modification of the method of Pierce (53). 
Control experiments. The control relationship between EVF and Pc-Πc in the 
lungs of 9 anesthetized sheep was previously determined (53). In order to confirm the 
consistency of the experiments, EVF in 2 additional control sheep was determined. In 
the first experiment, EVF was 3.9 after a 3 h period with no elevation in microvascular 
pressure (Pc-Πc = -12.5) and in the second experiment EVF was 4.2 with Pc-Πc = 5 
mmHg. These EVFs were consistent with the EVF of 4.0±0.2 obtained in sheep without 
Pc elevation, and the EVF of 4.3±0.1 with Pc-Πc = 5 mmHg. Therefore, the new data 
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was combined with the previously determined data to establish the relationship between 
control EVF and Pc-Πc.  
Histamine experiments. 4 μg/kg/min of histamine phosphate was infused into a 
total of nine sheep for a three hour period. In 7 sheep, histamine was infused into the 
systemic venous circulation, while in 2 other sheep it was infused into the pulmonary 
venous circulation. In five of these experiments, the pressure control system was used to 
control LAP so that Pc was either 0 or 5 mmHg higher than Πc for the 3 h period. In four 
experiments, LAP was not elevated. Two protocols for histamine infusion were used to 
evaluate whether different histamine infusion locations affect EVF with or without LAP 
elevation. 
 
4.3 METHODS: ANALYSIS OF PREVIOUSLY REPORTED DATA 
Compliance estimation. To compare results of histamine infusion to increased 
systemic venous pressure, data previously reported by Laine et al. (90) was analyzed. 
Briefly, the effect of systemic venous pressure elevation on lung edema formation was 
determined by elevating superior vena caval pressure (SVCP) of anesthetized sheep (n = 
8) by inflating a balloon occluder placed above the level of the azygos vein. Left atrial 
pressure was then controlled by partially inflating a balloon occluder inserted into the 
left atrium with and without elevating SVP to 10 mmHg for three hours. The amount of 
fluid present in the lung was determined from wet-to-dry weight ratios, similar to the 
current study.  
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Endotoxin infusion. Similarly, to compare results of histamine infusion to 
endotoxin infusion, data previously reported by Gabel et al. (53) was analyzed. Briefly, 
the effect of endotoxin infusion (1μg/kg) on lung edema formation was determined in 
anesthetized sheep (n = 6). LAP was varied by inflating a balloon occluder placed in left 
atrium. The amount of fluid present in the lung was determined from the wet-to-dry 
weight ratios, as in the current study. The resulting Edemagenic Gain for the endotoxin 
infusion group was compared to histamine and SVCP elevation groups. 
 
4.4 RESULTS 
Edemagenic Gain. Simultaneously solving Eqs. 3.1, 3.4, 4.1, and 4.2 and 
rearranging (See details in Appendix D) results in a ratio of ΔV to Δ(Pc-σ ·Πc). This new 
equation is termed “Edemagenic Gain” (EG). 
( )Edemagenic Gain  = 1
L f
c c L f
C R KV
P R Kσ
⋅ ⋅Δ =Δ − ⋅Π + ⋅  (4.3)
Edemagenic Gain can be expressed in the form of a classical feedback system relating 
the tendency to store excess interstitial volume to the parameters C, RL and Kf. 
Edemagenic Gain is represented in the form of a “transfer function” relating an input 
variable, Δ(Pc-σ ·Πc), to an output variable, ΔV (Fig. A-6A). The possible ranges of 
parameters derived from the literature are listed in Table B-2.  
 Compliance-Dominated and Multivariate gains. Equation 4.3 degenerates into 
an even simpler form when the combination of RL·Kf is either much greater or less than 
1. 
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When RL·Kf is much larger than 1, Edemagenic Gain is “Compliance-Dominated”, and 
when RL·Kf is much less than 1, Edemagenic Gain is “Multivariate”. Although Kf is 
smaller than 1, RL can have fairly large values (see Table B-2). Therefore, the value of 
RL·Kf is larger than 1 when RL is elevated, even if Kf varies markedly. These results are 
summarized in Fig. A-6B. 
Effect of histamine. Figure A-7 illustrates the change in EVF plotted as a function 
of Pc-Πc for each experiment. The histamine EVFs were significantly higher than the 
control EVFs at baseline Pc-Πc and for Pc-Πc = 5 mmHg. The location of histamine 
infusion had no effect on EVF. In the two experiments with histamine infusion into the 
pulmonary venous circulation, EVFs were 4.7 without LAP elevation and 4.9 with LAP 
elevation. These EVFs were consistent with EVFs from the experiments with histamine 
infusion into the systemic venous circulation (with EVFs 4.5±0.2 without LAP elevation 
and 5.1±0.3 with LAP elevation). The estimate of Edemagenic Gain for the control 
group is 0.018 ml/g·mmHg, and 0.034 ml/g·mmHg subsequent to histamine infusion.   
Compliance estimation. Figure A-8 illustrates the change in EVF resulting from a 
change in effective microvascular driving pressure in both control and the SVCP 
elevation groups. When LAP was elevated above control, a greater amount of pulmonary 
fluid accumulated in animals with elevated SVCP levels than the control group with 
normal SVCP. The estimate of Edemagenic Gain of the SVCP elevation group is 0.069 
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ml/g·mmHg, and that of the control group is 0.018 ml/g·mmHg. Assuming a high RL 
(Fig. A-8B), the interstitial compliance of the SVCP elevation group is therefore 0.069 
ml/g·mmHg.  
Comparison between effects of histamine and endotoxin infusion. Figure A-8 
illustrates the change in EVF in response to a change in effective microvascular driving 
pressure in the control case, as well as with histamine infusion, endotoxin infusion, and 
SVCP elevation. Edemagenic Gain was the lowest in the control case (0.018 
ml/g·mmHg). Edemagenic Gain of the endotoxin group (0.112 ml/g·mmHg) was greater 
than the histamine (0.04 ml/g·mmHg) and SVCP elevation groups (0.069 ml/g·mmHg).  
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5. VENOMOTION MODULATES LYMPHATIC PUMPING IN THE BAT WING 
 
5.1 METHODS  
Bat preparation. Experimental procedures and animal care were performed in 
compliance with the Texas A&M University Institutional Animal Care and Use 
Committee. With a few notable exceptions, experimental procedures were similar to 
those employed by Widmer et al. (152, 153). Briefly, Pallid bats (n=8) were maintained 
in a colony for over two years before experimentation. Bats were trained to participate in 
experiments without anesthesia, lying in a plastic box with their wing extended outside 
of the box. Following an established schedule, no bats were used for experimentation 
more than once per week, and no experiment lasted more than six hours. Bats were 
placed in a plastic box attached to a temperature-controlled glass plate (Olympus Tokai 
Hit) set at 27°C. The vasculature was visualized with an intravital microscope (Olympus 
BX61WI) utilizing a water-immersion lens at 400X magnification, and the image was 
recorded at 30 frames per second via digital video recorder (Panasonic KR222 S-Video 
Camera). Custom video caliper software was developed (LabView 7.1) to quantify 
vascular diameters from video recorded at 30 Hz.  
Vessel selection. The relative position of venules and lymphatic vessels was 
similar in all bats (Fig. A-9). The location selected for study was upstream of the first 
arteriolar bifurcation between the third and fourth phalanges. Venules at this location 
averaged 90-110 μm in diameter and were located between arterioles and lymphatic 
microvessels. Only spontaneously contracting lymphatic microvessels (12-25 μm 
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diameter) adjacent to venules were studied. At the selected location, the video was 
recorded for at least 5 minutes to ensure a stable baseline (152, 153).  
Procedures for correlating venomotion and lymphatic vessel contraction. Two 
sets of experiments were conducted. In the first set of experiments, the role of naturally 
existing venomotion in lymphatic pumping was evaluated without any particular 
intervention. For each venomotion cycle, peak diastolic and systolic venular diameters 
(DV) as well as corresponding lymphatic microvascular diameters (DL) were 
simultaneously recorded as a function of time. From these data, critical values were 
derived, including frequency of venular contraction (fV), frequency of lymphatic 
contraction (fL), magnitude of diameter change for each venomotion cycle (ΔDV), the 
rate of change of venous diameter during the venomotion cycle (dDV/dt), and the time 
delay (Δt) between peak systolic venular diameter and the beginning of lymphatic vessel 
contraction. For each cycle, the venomotion period (T) was determined from the time 
between two consecutive venular dilations. Cross-sectional area (AL) of lymphatic 
microvessels was calculated from measured diameter (DL) assuming a cylindrical 
conformation. To evaluate effectiveness of the extrinsic expansion and compression of 
the lymphatic microvessel by venomotion, only passive changes in the cross-sectional 
area were considered. Changes in lymphatic microvascular cross-sectional area due to 
active contraction were neglected. Active change in lymphatic microvascular diameter 
was distinguished from passive change by tracking the walls of the lymphatic 
microvessel. Walls moved towards each other during active contraction.  
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Procedures to abolish venomotion. In the second set of experiments, the causal 
relationship between venomotion and lymphatic microvascular contractions was 
evaluated by abolishing venomotion. Davis et al. previously reported that an increase in 
venular transmural pressure dilated venules and abolished venomotion (30). In the 
present study, venular transmural pressure was increased and venomotion was abolished 
by completely occluding the venules downstream from the point of observation. Venules 
were selectively occluded using blunt glass micropipettes to compress the venules 
against the glass plate under the wing. Lymphatic microvessel contraction frequency 
before and after selective venular occlusion (with a two minute equilibration period) 
were compared. 
Linear regressions and t-tests were performed using a statistics software package 
(SAS Institute, Inc.). A p value less than 0.05 was considered significant. 
 
5.2 RESULTS 
To characterize the topology of the lymphatic network, lymphatic microvessels 
adjacent to venules with diameter > 40 μm (exhibiting venomotion) were traced to 
venules with diameter < 25 μm (not exhibiting venomotion). In each experimental 
subject, lymphatic microvessels were paired with venules exhibiting venomotion. 
However, lymphatic microvessels were found to cross over and become paired with 
adjacent arterioles when venules were too small to exhibit venomotion (diameters < 25 
μm). 
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Figure A-10 depicts the peak systolic and peak diastolic venular diameters of a 
representative venule exhibiting venomotion and the passive change in the adjacent 
lymphatic vessel diameter. Discontinuities in the illustrated lymphatic vessel diameter 
correspond to the active change in diameter due to intrinsic contraction. The oscillation 
of venular diameter exhibits a natural variation in the magnitude as well as the 
frequency. This natural variation in venomotion allowed correlation of changes in 
venular diameter to changes in lymphatic diameters without requiring a particular 
intervention. Diameters of a representative venule and an adjacent lymphatic 
microvessel are illustrated in Fig. A-11 to indicate critical time points such as Δt (the 
time from c to d, Fig. A-11) and T (the time from b to b, Fig. A-11). 
Figure A-12 indicates the percent passive change in lymphatic microvascular 
cross-sectional area. A 58.5±15% change in cross-sectional areas of lymphatic 
microvessels was observed as adjacent venules dilated and contracted in the absence of 
active lymphatic contraction. This change in cross-sectional area compares to a ~67% 
change in cross-sectional area of the lymphatic microvessels due to active contractions 
of lymphatic microvessels reported by Benoit et al (7).  
Next the impact of spontaneous venular contractions on active lymphatic 
contractions was characterized. The distribution of the number of lymphatic 
microvascular contractions occurring after the onset of venous contraction expressed 
relative to the venomotion period (Fig. A-13) illustrates that the lymphatic microvascular 
contractions were correlated with venular activity (i.e. with venular dilation as well as 
contraction). In fact, 86% of lymphatic microvascular contractions occurred in the first 
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half of the venomotion period. Time point C in Fig. A-13 corresponds to the peak 
venular systole (occurring within the first 20.99±6% of the venomotion period). 
Figure A-14 illustrates the relationship between lymphatic microvascular 
contraction frequency and venomotion frequency. The slopes obtained from the linear 
regression of individual data sets indicated that venomotion frequency and lymphatic 
microvascular contraction frequency were positively correlated (one-sample t-test, 
p<0.001). 
The lymphatic muscle response was observed to vary with the magnitude and 
velocity of venomotion. Figure A-15 illustrates the time delay (Δt) between peak venular 
systole and the beginning of lymphatic vessel contraction as a function of magnitude and 
velocity of venomotion. With increased magnitude of venomotion, the time delay (Δt) 
before the onset of lymphatic contraction was significantly reduced (one-sample t-test, 
p<0.001, Figs. A-15A and B). As the velocity of venomotion increased, the time delay 
(Δt) was significantly reduced (one-sample t-test, p<0.001, Figs. A-15C and D). In one 
notable exception (vessel 7, Figs. A-15B and D), the association of magnitude as well as 
velocity of venomotion with the time delay was not evident, even though the lymphatic 
microvascular contraction frequency was positively correlated with venomotion 
frequency. This case was unusual because the lymphatic microvessel contracted at a 
much higher rate than the other vessels, and a relatively large percentage (35%) of its 
contractions occurred during the last 70% of the venomotion period.  
Complete occlusion of the venules downstream from the observation point 
abolished venomotion in accord with a previously reported study (30). Figure A-16A 
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depicts the diameter of a representative venule before and after the complete occlusion 
of the venule downstream from the point of observation. Figure A-16B illustrates the 
distribution of lymphatic contractions before and after the venular occlusion. A 
54.3±20% decrease in lymphatic contraction frequency was observed when venomotion 
was abolished (p<0.001). 
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6. DISCUSSION AND CONCLUSIONS* 
 
6.1 SPECIFIC AIM 1  
The present work provides the first algebraic characterization of interstitial fluid 
balance resulting from the interaction of microvascular, interstitial and lymphatic 
function. This novel theoretical framework addresses several limitations inherent in 
conventional quantitative approaches (40). First, by allowing interstitial fluid pressure 
(Pi) and protein concentration (Ci) to vary with interstitial inflow and outflow, the 
present analysis requires a minimal number of assumptions. Most notably, Pi and Ci 
were not assumed constant (40), but were formulated in terms of microvascular and 
lymphatic parameters (Eq. 3.8). Second, by exploiting an existing algebraic description 
of the lymphatic system (38), this novel formulation does not neglect the feedback 
provided by lymphatic function. That is, while other reports are limited to the effect of 
interstitial fluid pressure on lymphatic function (7, 106), this work includes the effect of 
lymphatic function on interstitial fluid pressure. Third, this approach goes beyond 
describing interstitial fluid balance only in terms of conservation of mass, by introducing 
the concept of inflow and outflow resistances (Fig. A-3). The reciprocal of the 
microvascular filtration coefficient (1/Kf) is revealed to be an inflow resistance, a natural 
counterpart to the effective lymphatic resistance (RL).  
 
____________ 
* Part of this section is reprinted with permission from “Edemagenic gain and interstitial 
fluid volume regulation” by R. M. Dongaonkar, C. M. Quick, R. H. Stewart, R. E. 
Drake, C. S. Cox, Jr., and G. A. Laine, 2008. Am J Physiol Regul Integr Comp Physiol 
294: R651-R659, Copyright [2008] by The American Physiological Society.  
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Fourth, the resulting approach reveals that steady-state interstitial fluid pressure 
depends on a simple ratio of 1/Kf and RL. Surprisingly, interstitial compliance has no 
effect on steady-state interstitial fluid pressure. Fifth, since the results can be represented 
by algebraic equations, the present work provides a general solution in terms of 
physiologically-relevant parameters. Unlike published results of numerical simulations 
which assume very specific values of parameters (12, 13, 22, 70, 71, 129, 166), the 
present solution can be easily customized to represent a particular experimental 
condition without resorting to solving differential equations. Sixth, this approach applies 
the familiar balance point concept (62, 67) to characterize interstitial fluid balance. The 
resulting graphical approach (Fig. A-4) provides a novel means to conceptualize the 
complex process of fluid balance without having to contemplate the interaction of eight 
separate equations (Eqs. 3.2-3.7). Taken together, the present work develops a novel 
theoretical framework that yields critical insights into the complex interaction of 
microvascular, interstitial, and lymphatic function. 
Algebraic formulation of interstitial fluid volume and protein regulation. Unlike 
conventional approaches that require numerical solutions (12, 13, 22, 70, 71, 129, 166), 
the present work derived a series of simple algebraic formulas characterizing interstitial 
fluid volume and protein regulation. The resulting approach integrated simplified 
equations (Eqs. 3.2-3.7) that characterize the microvasculature, interstitium, and 
lymphatic system using the classical control theory concepts of linearity and time 
invariance (34, 49). The benefits of this approach are fourfold. First, the resulting block-
diagram (Fig. A-1) promotes intuitive understanding of the interrelations between 
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subsystems. Second, this approach aids experimental design by separating parameters 
that characterize the system (σ, Kf, RL, and C) from variables that are experimentally 
manipulated or measured (Pc, Cc, Pout, Pi and Ci). Third, the resulting algebraic solutions 
can be easily customized for different organs by altering parameter values. Fourth, the 
simple results embodied in Eq. 3.8 provide a level of conceptual clarity that leads to new 
insights. For instance, it is evident that interstitial compliance has no effect on steady-
state interstitial fluid pressure. Equation 3.8 provides a new tool for physiologists to 
study the physics of interstitial fluid balance. None of these four benefits can be realized 
via conventional approaches that require numerical solutions. 
Reconceptualizing interstitial fluid balance with inflow and outflow resistances. 
A singular benefit of expressing interstitial fluid pressure with an algebraic function is 
that it leads to a new framework to understand interstitial fluid balance. Reformulating 
the equations describing microvascular filtration as a transfer function (34, 49) relating a 
microvascular driving pressure ([(Pc-Pi)-ασ (Cc-Ci)]) to an inlet flow (Jv) results in an 
effective resistance to microvascular filtration equal to 1/Kf. Similarly, Drake et al. (38) 
characterized lymphatic drainage as a transfer function relating a lymphatic driving 
pressure (Pi+Pp-Pout) to an outlet flow (JL), resulting in an effective lymphatic resistance 
(RL) (Eq. 3.3). When combined, these transfer functions suggest an electrical circuit 
analogy consisting of two resistances in series (Fig. A-3A). Three new concepts are 
generated by this electrical analogy. First, the ratio of RL and 1/Kf determines interstitial 
fluid pressure (Fig. A-3A). In fact, the relative values of RL and 1/Kf determine whether 
Pi approaches the effective microvascular driving pressure (when RL>1/Kf) or effective 
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lymphatic pumping pressure (when RL<1/Kf). Second, the sum of RL and 1/Kf determines 
the total resistance and thus lymph flow. Interstitial fluid pressure and lymph flow can 
therefore be regulated independently. Third, there is a natural analogy to regulation of 
capillary pressure (Fig. A-3B). Notably, capillary pressure also results from the ratio of 
inflow (arteriolar) and outflow (venular) resistances, and is unaffected by (capillary) 
compliance (120).    
Steady-state interstitial fluid pressure is not affected by interstitial compliance. 
The belief that interstitial compliance affects interstitial fluid pressure can be traced to 
the original work of Guyton et al. (63). Clearly, interstitial compliance by definition 
relates a change in interstitial fluid volume to a change in interstitial fluid pressure. 
However, the present work reveals that the absolute value of interstitial fluid pressure in 
steady state is not affected by interstitial compliance (Eq. 3.8a). Instead, steady-state 
interstitial fluid pressure is only a function of the resistances to interstitial fluid flow 
(1/Kf and RL) and driving pressures ([Pc-ασ (Cc-Ci)] and [Pout -Pp]) (Fig. A-3). The 
irrelevance of interstitial compliance to interstitial fluid pressure is illustrated by a series 
of experiments in which interstitial compliance is experimentally increased by infusing 
inflammatory agents or inducing trauma (132). Although the significant increase in 
interstitial fluid volume was sustained, the interstitial fluid pressure eventually 
approached baseline values (99, 132). Small persistent deviations from baseline values 
may have been the result of confounding alterations in microvascular permeability (4, 
108, 132). Once interstitial fluid pressure is determined by the ratio of inflow and 
outflow resistances, interstitial storage capacity, characterized by the interstitial fluid 
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volume-pressure relationship, determines the corresponding interstitial fluid volume 
(Fig. A-2A). Nonetheless, interstitial compliance is a critical parameter that affects the 
susceptibility of an organ to edema formation, characterized by the concept of 
Edemagenic Gain (34). 
Validity of assumptions. To arrive at the simple algebraic solutions in the present 
work (Eq. 3.8), a number of assumptions were required. The first set included 
assumptions that are commonly made when modeling microvascular filtration. Focusing 
on whole-organ fluid balance, the common assumption was made that the interstitial 
space within an organ behaves as a well mixed compartment—there is no concentration 
gradient across interstitial space (147). This assumption may result in an overestimation 
of the flow of fluid and proteins across microvascular membrane when microvascular 
filtration is low (147). Although several equations are reported that describe 
microvascular protein extravasation, the Taylor-Granger Equation (Eq. 3.3) was 
selected, because it is relatively simple and has been experimentally validated (147). 
This equation tends to overestimate microvascular protein extravasation when 
microvascular filtration is low, but approaches the well-accepted nonlinear Patlak-
Hoffman formulation (123) with increasing microvascular filtration (see Appendix C). A 
less-common set of assumptions is required specifically for the present work. Although 
all variables characterizing microvascular, interstitial, and lymphatic function have 
nonlinear relationships, for conceptual clarity they were represented with linear 
relationships (Eqs. 3.2-3.7). Linearization incurs minimal error if either the variables 
vary within a small range, or the relationships are treated as piecewise linear (12, 22, 
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70). The interstitial fluid volume-pressure relationship is particularly nonlinear, since the 
slope increases dramatically at higher hydration levels (63). This particular nonlinearity 
has minimal impact in the present work, because interstitial compliance has no effect on 
steady-state interstitial fluid pressure (Eq. 3.8a). Another critical assumption of linearity 
is embodied by the description of lymphatic function, appropriated from Drake et al. 
(38). Two critical parameters, RL and Pp, were derived empirically, and represent the 
slope and intercept of the lymphatic outflow-pressure relationship. As has been argued 
previously(6), RL and Pp do not represent the physical resistance to lymph flow or the 
pressure developed by lymphatic contractions. Recently, RL and Pp have been revealed to 
be related to both lymphatic vessel contractility and contraction frequency (126). Also, 
parameters characterizing microvascular filtration are typically reported in units per 
weight. Because lymphatic parameters characterize whole-organ behavior, they must be 
normalized to make their units consistent. Finally, to illustrate the ability of the resulting 
equations (Eq. 3.8) to predict interstitial fluid pressure and protein concentration, 
specific parameter values had to be assumed (Table B-1). Because the parameter values 
reported from the literature resulted from different animal models, organ systems, and 
experimental interventions, their range were relatively large. In the end analysis, 
however, the fact that predicted values compared favorably to measured values provides 
the greatest argument for the validity of the assumptions used in the present work. 
Graphical balance point approach permits intuitive conceptualization of complex 
problems. The algebraic solutions developed in the present work (Eq. 3.8) are 
manifestations of a balance-point characterization of interstitial fluid volume and protein 
 40
regulation. Like Guyton, who used a balance point approach to characterize heart-arterial 
interaction resulting from an equilibrium between venous return and cardiac output (62, 
67), microvascular-lymphatic interaction resulting from an equilibrium between the 
inflow and outflow of fluid and proteins (Figs. A-1A and B) is characterized in the 
present work. Although numerical approaches to solve the interstitial fluid flow 
equations are powerful enough to include even relatively unimportant details, the 
graphical balance point approach derived from Eq. 3.8 is simple enough to reveal 
fundamental behaviors. For instance, the graphical balance point approach can be used 
to quickly identify the effect of changing any one parameter on interstitial fluid pressure 
and lymph flow. Figure A-4A illustrates that increasing Kf shifts the balance point (from 
A to B), yielding higher interstitial fluid pressure and lymph flow. Figure A-4B 
illustrates that increasing RL shifts the balance point, yielding higher interstitial fluid 
pressure and lower microvascular filtration. Figure A-4C illustrates that increasing 
capillary pressure (Pc) shifts the balance point, yielding higher interstitial fluid pressure 
and lymph flow. Figure A-4D illustrates that increasing lymphatic outlet pressure (Pout) 
shifts the balance point, yielding higher interstitial fluid pressure and lower 
microvascular filtration. Perhaps more importantly, this graphical approach can reveal 
surprising behavior resulting from the interaction of parameters. For instance, although 
simultaneous increase in Kf and RL (shifting the balance point from A to B in Fig. A-4E) 
will yield higher interstitial fluid pressure and thus volume, microvascular filtration and 
lymph flow can remain unchanged. The common practice of using lymph flow to 
estimate Kf (40) may therefore fail. Conversely, an increase in Kf, if accompanied by a 
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decrease in RL, (shifting the balance point from A to B in Fig. A-4F) will yield increased 
microvascular and lymphatic flow without a corresponding change in interstitial fluid 
pressure. In fact, interstitial fluid volume would remain unchanged. Use of gravimetric 
approaches to infer changes in Kf (40) would therefore fail. These simple examples 
illustrate how this novel graphical approach can be used in the basic sciences to 
challenge established scientific techniques, in the clinical sciences to explore new ways 
to compensate for changes in properties such as increases in microvascular permeability 
(Fig. A-4A), and in education to introduce new students familiar with the balance point 
concept to integrated interstitial fluid balance. The ultimate contribution of the present 
work, however, may be that it provides a powerful analytical tool, yet is relatively 
simple to use. 
 
6.2 SPECIFIC AIM 2 
A new concept has been developed, referred to as “Edemagenic Gain”, relating 
changes in effective microvascular driving pressure to changes in interstitial fluid 
volume, and related to the three most important phenomena affecting fluid balance—
microvascular filtration, lymphatic function, and interstitial fluid storage capacity (Eq. 
4.3). By making simplifying assumptions, it was possible to derive a simple algebraic 
formula for Edemagenic Gain. The resulting first-order approximation was rearranged to 
separate parameters characterizing structure (i.e., microvascular permeability, effective 
lymphatic resistance, and interstitial compliance) from input and output variables 
characterizing function (i.e., change in effective microvascular driving pressure and 
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change in interstitial fluid volume). The resulting formulation presents the solution to 
classical fluid balance equations in a form recognizable as a classical negative feedback 
system (Fig. A-6A). Thus, by accepting the cost of losing a degree of accuracy, the 
benefit of conceptual clarity can be reaped that is not currently available from complex 
numerical simulations.  
The concept of gain as an integrational approach to interstitial fluid dynamics. 
Mathematically modeling the dynamics of interstitial fluid balance has had a long 
history, (12, 13, 22, 64, 70, 71, 129, 166) and resulted in concepts such an edema “safety 
factor” that have played a significant role in our current understanding of edema 
formation (66). Typically, these approaches focused solely on hemodilution or 
hemorrhage, and the role of vascular permeability. Given how often the concepts of 
vascular permeability and interstitial compliance are invoked, it is perhaps overlooked 
that Kf is a “black box” parameter relating hydrostatic and colloid osmotic pressure 
gradients to microvascular filtration and that C is a “black box” parameter relating 
interstitial fluid volume to pressure. The “black box” approach to interstitial fluid 
balance has further been refined. Kf, for instance, has been further reduced into smaller 
black boxes, such as “hydraulic conductivity” and “surface area” (109, 110). The 
introduction of molecular biology analytical techniques has provided further 
opportunities to provide mechanistic interpretations, especially in the understanding of 
changes in interstitial compliance (128, 132). Although this process of reductionism has 
led to fundamental new understanding of the individual physiological processes involved 
in edema formation and resolution, it has been unclear how these mechanistic elements 
 43
interact with each other and thus affect interstitial fluid volume as a global variable, the 
necessary step to bridge basic science to clinically-relevant research. The approach used 
in the present work therefore provides an integrational approach that complements 
reductionist approaches, providing the means to 1) predict the implications of changes in 
any of the currently identified mechanistic elements on interstitial fluid volume, 2) 
determine the dominant mechanisms that have the greatest impact on interstitial fluid 
volume, 3) identify which parameters must first be determined before ascribing edema 
formation to any one process. Our integrational approach is complementary to 
mechanistic studies, and in the present case, has at least identified what remains 
unknown and requires further study. 
Necessary components to describe a physiological process as a gain. In order to 
derive an algebraic formula that characterizes a complex physiological process in terms 
of a constant “gain”, it is necessary to formulate the system as 1) linear, 2) first-order, 
and 3) time-invariant (49, 89). Even though most physiological processes are highly 
nonlinear, approximating them as linear is permissible when changes in the variables of 
interest are small. When variables change sufficiently to make nonlinear effects 
significant, it is common practice to treat the system as “piecewise linear”. For example, 
the interstitial fluid pressure-volume relationship can be approximated as a combination 
of two linear relationships corresponding to two different levels of hydration (12, 22, 
70). Similarly, although most physiological processes can be overwhelmingly complex, 
approximating them as first-order (i.e., eliminating secondary effects) is permissible 
when the secondary effects are small. For instance, to arrive at the relationship between 
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lymphatic driving pressure and lymph flow in Drake-Laine formulation (38), 
reabsorption of the lymphatic fluid back into circulation in lymph nodes is neglected. 
The final criterion, time-invariance, requires that all parameters except the input and 
output variables (i.e., interstitial fluid volume and microvascular pressure) have constant 
values. That is, parameters such as C, RL, Kf and σ are relatively constant, and do not 
vary appreciably from moment to moment. If any particular intervention alters one of 
these parameters, then the gain is said to have changed. Taken together, the assumptions 
that the system is linear, first-order, and time-invariant make it possible to avoid using a 
highly complex convection-diffusion transport model which must be solved numerically. 
Although numerical solutions can include many relevant details (12, 13, 22, 70, 71, 129, 
166), they cannot be expressed as a simple algebraic formula. In fact, such solutions can 
only be plotted graphically. Plotting volume as a function of just four parameters (C, RL, 
Kf and σ) cannot be accomplished in a single graph. Numerical solutions thus suffer 
from a loss of conceptual clarity, since they lack an explicit relationship of cause and 
effect, and require the knowledge of numerous variables that cannot be retrieved 
experimentally. 
Reinterpreting the Lymphatic “Effective Resistance”. The Drake-Laine 
lymphatic system model characterizes the lymphatic flow as a function of two lumped 
parameters: one describing the slope of the pressure-flow relationship and one describing 
the intercept. Using a convenient analogy to an electric circuit, these quantities have 
been referred as “effective lymphatic resistance” (RL) and “lymphatic pump pressure” 
(Pp). Values for these parameters have not yet been predicted from first principles, but 
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are estimated from linear regression of measured data. They are therefore empirical 
(descriptive) parameters (38). To date RL and Pp have been used to describe lymphatic 
function in a number of organs (39, 42, 44, 91, 93), but have yet to be assigned particular 
physiological interpretations. Much like Kf, a “black box” parameter relating hydrostatic 
and colloid osmotic pressure gradients to microvascular filtration and C, a “black box” 
parameter relating interstitial fluid volume to pressure, RL and Pp are similar “black box” 
parameters which relate lymphatic outflow to interstitial fluid pressure. Since 
transserosal flow, flow across the serous membrane which encloses several organs, is 
ultimately collected by lymphatics and returned to systemic circulation, transserosal flow 
is accommodated by the Drake-Laine model. The historical use of the term “effective 
resistance” to describe the empirically-derived slope of the line of the pressure gradient-
flow relationship is unfortunate and has caused some consternation, since this empirical 
relationship clearly arises from an active pumping of lymph, rather than a purely passive 
process as implied by the term “resistance” (6). 
Edemagenic Gain suggests a novel structure-based classification of edema. The 
equation used in the present work to approximate Edemagenic Gain (Eq. 4.3) assumes an 
even simpler form (Eq. 4.4) when specific parameters are either very large or small. In 
the first case, when effective lymphatic resistance is significantly elevated, RL·Kf can 
become much larger than 1. The value of 1+RL·Kf thus becomes approximately equal to 
RL·Kf and EG can be approximated by C. Under such conditions, interstitial compliance 
alone determines Edemagenic Gain and thus the susceptibility to edema, irrespective of 
the particular value of the microvascular filtration coefficient (Fig. A-6B). In other 
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words, Edemagenic Gain becomes “Compliance-Dominated”. In most other cases, 
however, RL is relatively small, including edema caused by enhanced microvascular 
permeability. Edemagenic Gain then depends on the combination of interstitial 
compliance (C), effective lymphatic resistance (RL), and microvascular permeability (Kf) 
(Fig. A-6B). In this case, Edemagenic Gain is “Multivariate”. This analysis has therefore 
revealed two types of gain; “Compliance-Dominated” approximately equal to C and 
“Multivariate” dependent on C, RL and Kf. In both cases, interstitial compliance plays a 
significant role in edema formation. This structure-based classification of edema 
provides a novel approach to estimate interstitial compliance on one hand, and a novel 
insight into the causes of edema on the other. 
Edemagenic Gain provides a novel approach to estimate interstitial compliance. 
Conventional techniques to estimate interstitial compliance require recording changes in 
both interstitial fluid volume and interstitial hydrostatic pressure. Whereas methods to 
measure changes in tissue fluid volume are fairly accurate and stable, measuring 
interstitial hydrostatic pressure is problematic. Wiig et al. reported significant deviation 
when comparing interstitial hydrostatic pressure measurements derived from 
micropipette techniques, chronic perforated and porous capsule techniques, and wick 
methods (159-162). The concept of Edemagenic Gain provides an alternative approach 
that eliminates the need to measure interstitial fluid pressure. By increasing effective 
lymphatic resistance (or alternatively increasing lymphatic outlet pressure), Edemagenic 
Gain becomes equal to interstitial compliance (C) (Eq. 4.4). Only changes in interstitial 
fluid volume and microvascular hydrostatic pressure therefore must be measured to 
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estimate C. This method can be particularly useful to determine chronic changes in 
tissue compliance, especially in the myocardium and lungs where interstitial fluid 
pressure measurement is confounded by tissue motion (113). Indeed, since the edema in 
the SVCP elevation group described in Fig. A-8 was caused by an intervention that 
decreased lymphatic flow (comparable to impaired outflow edema), Edemagenic Gain is 
expected to depend only on the interstitial compliance (Fig. A-6B). Interstitial 
compliance estimated using our novel method (  = 0.069 ml/g·mmHg) is within the 
range previously estimated by conventional methods (Table B-2). 
Edemagenic Gain provides a novel insight into the causes of edema. Determining 
how a physiologic intervention causes edema is particularly difficult, because it is not 
possible to directly measure microvascular permeability, effective lymphatic resistance, 
and interstitial compliance in a single experiment. The present work uses the example of 
histamine-induced edema to illustrate how the concept of Edemagenic Gain can 
reconcile disparate reports. First, several reports suggest that increases in the 
microvascular filtration coefficient are responsible for histamine-induced edema (11, 88, 
108, 115, 124). Second, inhibition of lymph flow by histamine (47, 127), suggests 
changes in lymphatic function could be responsible for histamine-induced edema. Third, 
interstitial fluid pressure measurement studies have demonstrated that interstitial 
compliance increases significantly after histamine infusion, suggesting changes in 
compliance alone may be responsible for histamine-induced edema, as it is for edema 
induced by other inflammatory agents (3, 9, 10, 57, 83, 86, 87, 119, 130, 134, 164). 
From an experimental standpoint, our results (slope, Fig. A-7) clearly indicate that 
 48
histamine increases Edemagenic Gain by approximately a factor of two. However, our 
theoretical formulation (Eq. 4.3) suggests that all three parameters C, RL and Kf may 
determine the extent of edema formation. In this case, there is not enough information 
contained in the data to exclude any of the three postulated edemagenic mechanisms.   
Active regulation of C, RL and Kf. Until recently, interstitial compliance and 
effective lymphatic resistance were considered as passive properties (63, 66). Recent 
studies, however, have suggested that these properties are actively regulated. Effective 
lymphatic resistance, for instance, has been shown to be a regulated property, since it is 
affected by several neurohormonal factors that modulate lymphatic function (46, 47, 73, 
76, 127, 146). Furthermore recent studies have suggested that interstitial compliance is 
not only passively affected by the level of hydration, but also by modulation of β1-
integrin adhesions (87, 128, 132, 163, 165). The present work presents a framework to 
study the effect of acute to chronic regulation of the structural properties C, RL and Kf. 
Not only can the Edemagenic Gain be used to identify changes in critical properties that 
produce edema, such as permeability, it can conversely identify structural changes 
resulting from edema, such as changes in interstitial compliance following fibrosis. 
Generalizing Edemagenic Gain: incorporating changes in σ and Πi. In the 
formulation of Edemagenic Gain given by Eq. 4.3, only three parameters, C, RL and Kf, 
determine the relationship between the change in effective microvascular driving 
pressure and the change in interstitial fluid volume. In this particular formulation of 
Edemagenic Gain, there are two constants: the microvascular reflection coefficient (σ), 
which characterizes the relative microvascular permeability to proteins, and interstitial 
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colloid osmotic pressure (Πi). Changes in the reflection coefficient as well as interstitial 
colloid osmotic pressure, however, can affect interstitial fluid volume. The values of 
σ and Πi were not determined in the present study, although there is evidence that 
histamine and endotoxin decrease σ and may increase Πi (19, 53, 108, 124). To take 
advantage of measurements of σ and Πi in future studies, Edemagenic Gain could be 
reformulated (see Appendix D) such that σ and Πi are variables (Eq. A6). In this case, the 
Edemagenic Gain is expressed as ΔV/Δ(Pc-σ⋅(Πc−Πi)). Not only can this more general 
formulation incorporate changes in σ or Πi, it can capture such phenomena as “protein 
washdown”. This more general formulation degenerates into ΔV/Δ(Pc-σ⋅Πc), as in Eq. 
4.3, when variables σ and Πi are constant. If all the parameters change (e.g., Pc, Πc, 
Πi and σ) with a particular intervention, then they would all need to be independently 
measured. The measurement of σ and Πi would allow more accurate estimation of the 
Edemagenic Gain. The process of simplification used in the present work could therefore 
be used as a guide for investigators developing new approximations of Edemagenic 
Gain. Caution is advised, however, a previous attempt to relate interstitial volume to 
effective microvascular driving pressures (53) oversimplified the equations, and the 
critical contribution of interstitial compliance was neglected (see Appendix D). 
Extrapolation of Edemagenic Gain estimations to different organs. The 
Edemagenic Gain formulation is general—no assumptions of a specific organ or 
parameter values were necessary to define EG in Eq. 4.3. To use the Edemagenic Gain 
formulation for a specific organ, the model should be evaluated and validated with 
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particular attention to the specific assumptions made for the organ under study. In the 
present study, for instance, values of C, RL and Kf listed in Table B-2 are used to 
characterize interstitial fluid balance in lung. The lung model has been well-studied over 
the last four decades, and the measurements for all three parameters (C, RL and Kf) have 
been determined (Table B-2). A dilemma may arise, however, when extrapolating the 
outcomes to other organ systems, especially those for which the measurements of the 
parameters are not available. In this case, either the unknown parameters must be 
determined before predicting the Edemagenic Gain, or the ranges of the permissible 
values of the parameters should be determined to estimate the range of Edemagenic Gain 
that can result. The sensitivity analysis presented in Table B-3 provides some guidance 
to determine how critical a particular parameter value is. In some specific cases (such as 
when the Edemagenic Gain is “Compliance-Dominated”), the particular values of 
parameters (such as RL and Kf) have a relatively small influence. Extrapolation of the 
present model implementation to other organ systems must be evaluated on a case-by-
case basis. 
Inflammatory agents have disparate effects on Edemagenic Gain. The concept of 
Edemagenic Gain can be used to characterize the extent to which specific inflammatory 
agents can sensitize tissues to edemagenic conditions. Both histamine and endotoxin are 
pro-inflammatory agents that can result in similar degrees of edema. However, 
pulmonary edema induced by endotoxin does not regress, even after significant 
reduction in effective lymphatic resistance (92). Analysis presented in Fig. A-8 provides 
a potential interpretation. The endotoxin group has a larger Edemagenic Gain (0.112 
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ml/g·mmHg) than either the histamine group (0.034 ml/g·mmHg) or the superior vena 
caval pressure elevation group (0.069 ml/g·mmHg). The endotoxin group is therefore 
approximately twice as sensitive to changes in effective microvascular driving pressure. 
Although these results are likely dose-dependent, this particular example suggests that 
endotoxin-induced edema is potentially more serious, less stable, and more likely to 
present as acutely fulminating edema. The concept of Edemagenic Gain does not provide 
a measure of edema, but instead provides an index of an organ’s susceptibility to edema 
formation. 
 
6.3 SPECIFIC AIM 3 
The present work demonstrates that venomotion modulates the pumping of 
lymph by both compressing adjacent lymphatic microvessels (32) and mechanically 
triggering intrinsic lymphatic contractions. First, venous dilation and contraction 
produced a significant change in lymphatic microvascular cross-sectional area. Second, 
lymphatic microvascular contractions were immediately preceded by a change in venular 
diameter (Fig. A-13). Third, venular and lymphatic vessel contraction frequencies were 
correlated (Fig. A-14). Fourth, the time delay between the peak venular systole and the 
onset of lymphatic microvascular contraction was negatively correlated with venomotion 
magnitude and velocity (Fig. A-15). Fifth, lymphatic microvessels are paired with 
venules that exhibit marked venomotion, but with arterioles when adjacent venules lack 
venomotion. Sixth, a decrease in lymphatic contraction frequency was observed when 
venomotion was abolished (Fig. A-16). Taken together, these pieces of evidence are 
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consistent with both extrinsic pumping of lymph by venules and mechanical triggering 
of intrinsic lymphatic contractions. These results also imply that with venular-lymphatic 
coupling, extrinsic and intrinsic lymph pumping mechanisms not only coexist, but also 
are coupled.  
Evidence of mechanical origin of venule-lymphatic coupling. The possibility that 
venular and lymphatic contractions are both initiated by a common neural, electrical, or 
humoral factor must be addressed. First, venules as well as lymphatic microvessels in 
bats are not innervated (25, 82, 155). If each pair of venules and lymphatic microvessels 
was jointly innervated in the bat wing, there would have to be a consistent delay before 
the initiation of lymphatic contraction. Second, there is no apparent connection between 
the muscular layers of venules and lymphatic microvessels to provide direct electrical 
conduction. Furthermore, there is not a one-to-one coordination of lymphangion and 
venular contraction cycles (Fig. A-14) that would be expected to accompany direct 
electrical conduction. With regard to the diffusion of a humoral factor, the diffusion 
distance for humoral factors to travel from venules to lymphangions (~30 microns) is too 
large for the small time delay (0.6 sec, 10% of the venomotion period) between venular 
and lymphatic contraction (Fig. A-13). None of these non-mechanical factors are 
consistent with all six observations presented above. In contrast, all six observations are 
consistent with the well-established phenomena of stretch-induced vascular muscle 
contraction (116).   
Abolishing venomotion to modulate lymphatic contraction. To ensure that the 
correlation of lymphatic vessel contraction with venomotion is causal and mediated by 
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mechanical stimulation, a mechanical intervention was required. It was not possible to 
establish causality by abolishing venomotion pharmacologically without incidentally 
inhibiting lymphangion contraction. The close proximity of the lymphatic microvessels 
to venules made it impossible to independently dose venules with drugs (e.g., calcium 
channel blockers). However, Davis et al. previously reported that raising venular 
transmural pressure abolishes venomotion in the bat wing (30). Therefore the venules 
were selectively occluded to raise their transmural pressures. Although, venular 
transmural pressures were not measured, the occlusion produced venular dilation and 
abolished venomotion. It is possible that in the process of occluding some venules, the 
adjacent lymphatic vessels may have been occluded. However, a previously reported 
increase in the lymphatic contraction frequency with elevated lymphatic transmural 
pressure (7, 75, 106) was not observed in any of the vessels in the present study (Fig. A-
16). The reduced lymphatic microvascular contraction frequency associated with 
abolished venomotion provides evidence that venomotion mechanically stimulates 
intrinsic contractions of adjacent lymphatic microvessels. 
Methodological challenges to quantifying relative contribution of extrinsic 
pumping. There are a number of notable methodological limitations particular to our 
unique animal model. First, only lymphatic microvessels that exhibited spontaneous 
contraction were studied, since they could be identified without the use of contrast 
agents that might affect lymphatic function (2). Although the selection of only these 
vessels introduces a selection bias, the result would be to underestimate the relative role 
of extrinsic pumping on lymph propulsion. Second, it was not possible to visualize the 
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entire length of a lymphangion while making accurate diameter measurements. It is 
therefore possible that compression of a lymphangion segment does not propel lymph 
through downstream valves, but merely acts to passively expand the portion of 
lymphangion outside the field of view. However, the observed percent change in 
lymphangion cross-sectional area caused by venomotion was comparable to the 
observed percent change in lymphangion cross-sectional area (67%) caused by intrinsic 
contraction reported by Benoit et al. (7) (Fig. A-12). Third, since the Pallid bats were 
lightly restrained, did not move during experiments, and have wings devoid of skeletal 
muscle, the only source of extrinsic compression of lymphangions arose from 
venomotion. Stresses within the wing membrane during flight, however, may provide 
another source of extrinsic propulsion of lymph. Fourth, the bat wing was not exposed to 
edemagenic challenges known to increase interstitial fluid pressure. The relative 
contribution of venomotion to lymph propulsion therefore may decrease when 
lymphangions are stimulated to contract with a greater force or with a greater frequency. 
Nonetheless, the 58.5±15% change in lymphangion cross-sectional area suggests that 
extrinsic propulsion of lymph due to venomotion plays as great a role as intrinsic 
lymphangion contraction in the normal resting state.  
Increasing effectiveness of lymph propulsion in the face of an edemagenic 
challenge.  This is the first work to offer evidence of coordination between intrinsic and 
extrinsic pumping of lymph. Such coordination may simply increase the efficiency of 
lymph propulsion. However, such coordination may also increase the effectiveness of 
lymphangion pumping in the face of an edemagenic challenge. The ability of 
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lymphangions to propel lymph depends on their contractility, diastolic function, preload, 
and afterload (7). Lymphatic microvascular compression due to venular expansion could 
enhance lymphatic microvascular contractility, increasing the “effective inotropy”. 
Similarly, lymphatic microvascular expansion due to venular contraction could facilitate 
faster lymphatic microvascular filling, increasing the “effective lusitropy”. In addition, 
venular compression of an upstream lymphangion may increase preload, and venular 
expansion of a downstream lymphangion may decrease afterload. Because these four 
behaviors can enhance the intrinsic lymph pump, venomotion may act as a previously 
unidentified anti-edema mechanism. For instance, locally heating the skin not only leads 
to greater microvascular filtration, but also increased venomotion magnitude, velocity, 
and frequency and thus possibly enhanced lymphatic function (15, 85). In fact, any 
phenomena that increase capillary and venular pressures can increase both microvascular 
flux and venomotion (30, 158).  
Implications for lymphatic-venule tethering and network structure. The ability of 
venomotion to mechanically modulate lymph flow in the bat wing would be influenced 
by three structural properties. First, the degree of mechanical coupling depends on 
properties of the tissue tethering one side of the lymphangion to the venule and the other 
side of the lymphangion to the adjacent interstitial matrix. If the intervascular tissue 
stiffness were too low, venomotion would not displace one wall of the lymphangion. 
Similarly, the tissue tethering the other wall of the lymphangion to the adjacent 
interstitial matrix must be sufficiently stiff to hold it in place, otherwise venomotion 
would merely displace the entire lymphatic vessel without compressing or expanding it. 
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Second, to ensure that venular and lymphangion contraction can remain coordinated 
throughout the network, the depolarization waves along venules and lymphatic 
microvessels must travel with similar velocities, or else venular and lymphatic 
contractions would eventually become discoordinated. Alternatively, there could be 
electrical discontinuities allowing resynchronization by mechanical triggering. Third, it 
would be expected that lymphangions would lie in close proximity only to venules that 
have significant venomotion. In fact, lymphatic microvessels do not lie adjacent to 
parallel venules with diameters <25 μm where the lack of smooth muscle precludes 
spontaneous venomotion (148). Furthermore, lymphatic microvessels tend to switch 
sides and lie adjacent to parallel arterioles where venomotion is diminished.    
Implications of interaction between extrinsic and intrinsic pumping of lymph. 
Although the rather pronounced venomotion of the bat wing may be unique (148), the 
coupling of intrinsic and extrinsic pumping may not be. Unlike common animal models, 
the bat wing model does not require anesthesia, which is known to decrease the 
magnitude of venomotion (26). Significant venomotion has not only been directly 
observed only in the bat wing, but has been inferred from venous pressure measurements 
in rabbit ear and dog limbs (72, 156, 157). Noddeland et al. (117) recorded rhythmic 
pressure oscillations in cannulated small veins of human feet and suggested that these 
oscillations were of venular origin. Recent recordings of the blood flow velocity in 
human feet by Lurie et al. (100, 101) exhibit rhythmic patterns similar to bat wing 
venular blood flow, suggesting a venular origin of the oscillations. Perhaps venomotion 
in the normal, resting state in other mammals is great enough to produce venomotion-
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enhanced propulsion of lymph. Even if this is not the case, the present work suggests 
that other manifestations of extrinsic pumping, such as that arising from contraction of 
skeletal muscle, might also trigger, coordinate, and enhance intrinsic lymphangion 
pumping. 
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Figure A-1.  Graphical representation of the balance point concept applied to 
interstitial fluid and protein flow. A) Graphical representation of the relationship 
between Pi and JV (Eq. 3.2) and Pi and JL (Eq. 3.4). Their slopes are equal to –Kf and 
1/RL, respectively. Steady-state values of Pi, JL and JV are represented by the 
intersection. B) Graphical representation of the relationship between Ci and JsV (Eq. 3.3) 
and Ci and JsL. (Eq. 3.5). Their slopes are equal to ασKf (1-σ)Cc-PS and (Pi+Pp-Pout)/RL, 
respectively. Steady-state values of Ci, JsV and JsL are represented by the intersection. 
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Figure A-2.  A) Block diagram of interstitial fluid volume regulation at steady-state 
constructed from Eqs. 3.2, 3.4 and 3.6a. The microvascular filtration coefficient (Kf) and 
the effective lymphatic resistance (RL) determine interstitial fluid pressure (Pi) by 
modulating microvascular driving pressure (part I) and lymphatic effective pumping 
pressure (part II). Pi is not affected by interstitial compliance (C). B) Block diagram of 
interstitial protein regulation at steady-state constructed from Eqs. 3.3, 3.5 and 3.6b. 
Structural parameters (Kf, σ, and PS) along with lymphatic outflow rate (JL) determine 
interstitial protein concentration (Ci). 
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Figure A-3. Steady-state interstitial fluid pressure regulation is analogous to 
microvascular pressure regulation. A) Representation of steady-state interstitial fluid 
pressure balance point in terms of inflow and outflow resistances. B) Representation of 
steady-state capillary pressure regulation in terms of arterial and venular resistances. 1/Kf 
and RL are analogous to arteriolar resistance (Ra) and venular resistance (Rv). The ratio of 
interstitial inflow resistance (1/Kf) and interstitial outflow resistance (RL) determines 
whether Pi approaches microvascular driving pressure [Pc-ασ(Cc-Ci)] or lymphatic 
effective pumping pressure (Pout-Pp). 
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Figure A-4.  Graphical balance point analysis illustrated in Fig. A-2 provides intuitive 
insight into interstitial fluid pressure regulation. Effect of changing various parameters 
and variables on interstitial fluid pressure (Pi), microvascular fluid filtration (Jv) and 
lymph outflow of fluid (JL) illustrated by a shift in the balance point from A to B. 
Subscripts indicate change from state 1 to state 2. Effect of increasing microvascular 
filtration coefficient Kf (A), increasing effective lymphatic resistance RL (B), increasing 
capillary pressure Pc (C), increasing lymphatic outlet pressure Pout (D), concomitant 
increase in Kf and RL increases interstitial fluid pressure, but maintains JV and JL (E), 
simultaneous increase in Kf and decrease RL increases JV and JL, but maintains interstitial 
fluid pressure (F). 
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Figure A-4 continued.  
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Figure A-4 continued.  
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Figure A-5. Microvascular protein extravasation rate (JsV) estimation using the 
Taylor-Granger formulation (JsVTG) (Eq. 3.3) is compared with the Kedem-Katchalsky 
formulation (JsVKK) (Eq. C1) and the Manning formulation (JsVM) (Eq. C3) assuming the 
Patlak-Hoffman formulation (JsVPH) (Eq. C2) is ideal (18). A) Ratio of errors R1=|JsVPH - 
JsVKK|/| JsVPH - JsVTG| as a function of JV compares the Taylor-Granger formulation with 
the Kedem-Katchalsky formulation assuming Ci/Cc = 0.1, 0.5 and 0.9 (σ = 0.6, PS = 
0.118). B) Ratio of errors R2=|JsVPH - JsVM|/| JsVPH - JsVTG| as a function of JV compares 
the Taylor-Granger formulation with the Manning formulation assuming Ci/Cc = 0.1, 0.5 
and 0.9 (σ = 0.6, PS = 0.118). The fact that R1 >1 and R2 >1 with increasing JV suggests 
that the Taylor-Granger formulation is a better approximation of the Patlak-Hoffman 
formulation. 
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Figure A-6:  A) Graphical representation of the Edemagenic Gain concept. 
Edemagenic Gain (EG) forms a “transfer function” relating changes in effective 
microvascular driving pressure Δ(Pc-σ ·Πc) to changes in interstitial fluid volume ΔV. B) 
Edemagenic Gain takes on a simpler form when parameters have large or small values. 
When the effective lymphatic resistance (RL) is significantly elevated (as in the case of 
impaired outflow edema), only interstitial compliance (C) determines Edemagenic Gain. 
In other cases, including enhanced inflow edema (as in the case of increased 
microvascular filtration), all three parameters, interstitial compliance (C), effective 
lymphatic resistance (RL), and microvascular filtration coefficient (Kf) determine 
Edemagenic Gain. 
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Figure A-7:  Extravascular fluid volume (EVF) of sheep lung as a function of effective 
microvascular driving pressure (Pc-Πc) for the control group (n = 11) and after infusion 
of histamine (n = 9). The regression line of the control and histamine data represented by 
solid and dashed lines, respectively. Edemagenic Gain for the histamine group is 
approximately double the control group (0.018 ml/g·mmHg vs. 0.034 ml/g·mmHg).  
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Figure A-8: Change in extravascular fluid volume (EVF) in response to change in 
effective microvascular driving pressure in controls, with histamine infusion, with 
endotoxin infusion, and superior vena caval pressure elevation (SVCP). Edemagenic 
Gains of the three intervention groups are larger than that of the control group (0.018 
ml/g·mmHg). The endotoxin group (0.112 ml/g·mmHg) has larger Edemagenic Gain 
compared to the histamine group (0.134 ml/g·mmHg) and SVCP elevation group (0.069 
ml/g·mmHg). 
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Figure A-9:  Vessel network structure in the Pallid bat wing and location of the region 
of interest. A – arteriole, V – venule, L – lymphatic microvessel. 
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Figure A-10: Illustration of the oscillation of venular diameter (peak systolic and peak 
diastolic only) with time in a representative venule exhibiting venomotion and 
corresponding passive change in adjacent lymphatic microvascular diameter. 
Discontinuities in the illustrated lymphatic vessel diameter correspond to the active 
change in diameter due to intrinsic contraction.   
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Figure A-11:   Illustration of critical time points along the contraction cycles of a 
representative pair of adjacent venule (V) and lymphatic vessel (L). a: beginning venular 
dilation, b: time of peak venular diastole, c: time of peak venular systole, d: onset of 
active lymphatic contraction. The time b to b represents the venomotion period. The 
time c to d represents the time delay (Δt) between peak venular systole and onset of the 
active lymphatic contraction. 
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Figure A-12:   Percent change in lymphatic microvascular cross-sectional area (%ΔAL) 
due to passive expansion and compression by adjacent venule exhibiting venomotion. 
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Figure A-13: Distribution of lymphatic microvascular contractions occurring after the 
onset of venous contraction expressed relative to the venomotion period (T). The 
bimodal distribution corresponds to venular dilation and contraction activity (within the 
first 20.99±6% of T). C corresponds to the time of peak venular systole that occurs 
within the venomotion period (b to b).  
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Figure A-14: Positive correlation between venomotion frequency (fV) and lymphatic 
microvascular contraction frequency (fL) with spontaneous venomotion (p<0.001, n=8). 
Linear regression analysis was performed using data from a five minute period. 
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Figure A-15:   The coordination between venomotion and lymphatic microvascular 
contractions depends on and the magnitude (ΔDV) and velocity (dDV/dt) of changes in 
venular diameter (n=8). Vessels 1-4 plotted separately from vessels 5-8 for clarity. A) 
Time delay vs. magnitude of changes in venous diameters for vessels 1-4. B) Time delay 
vs. magnitude of changes in venous diameters for vessels 4-8. As the magnitude of 
venomotion increases, the time delay (Δt) between peak venular systole and onset of 
lymphatic microvascular contraction is reduced (p<0.001). C) Time delay vs. velocity of 
vessel wall in vessels 1-4. D) Time delay vs. velocity of vessel wall in vessels 5-8. As 
the velocity of venomotion increases, the time delay between peak venular systole and 
onset of lymphatic microvascular contraction is reduced (p<0.001). 
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Figure A-16: Effect of venular occlusion on venomotion and contraction frequency of 
the adjacent lymphatic microvessel. A) Diameter tracing of a representative venule 
before and after complete venular occlusion shows venular dilation and abolished 
venomotion [as previously reported (30)] in response to increased venular transmural 
pressure. B) 54.3±20% decrease in lymphatic contraction frequency was observed with 
complete venular occlusion (n=8, p<0.001), indicating that venomotion mechanically 
triggers lymphangion contraction. Data could not be collected for approximately one 
minute while vessel was in the process of being occluded. 
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APPENDIX B 
 
Table B-1. A) Comparison between the predicted values of interstitial fluid pressure 
(Pi) and interstitial protein concentration (Ci) calculated from Eq. 3.8 and previously 
reported values. B) Effect of variation in Kf on estimated Pi and Ci. Increase in Kf results 
in increase in Pi and decrease in Ci. C) Effect of variation in σ on estimated Pi and Ci. 
Increase in σ results in decrease in Pi and Ci. [Values for Pp were assumed; α = 0.37 (70, 
71)] 
 
A 
Animal 
model 
Inter-
vention 
Values of other parameters Estimated Measured 
Pi Ci Pi Ci 
Dog lung Control 
RL = 76 (37), Kf = 0.07 (43, 
68), Pc = 7 (52), Cc = 58 (74), 
σ = 0.62 (122), PS = 0.07 
(122), Pp = 20, Pout = 2 
-2.2 
 
31 
 
-2.7 
(97) 
35 
(74) 
Dog 
skeletal 
muscle 
Base 
line 
RL = 200 (91), Kf = 0.007 (8), 
Pc = 24 (50), Cc = 54 (160), σ 
= 0.72 (122), PS = 0.03 (122), 
Pp = 25, Pout = 2 
-0.4 
 
23.3 
 
-0.1 
(160) 
22.4 
(160) 
Dog liver Control 
RL = 74 (91), Kf = 0.3 (61), Pc 
= 7 (94), Cc = 60 (94), σ = 
0.02 (122), PS = 1.6 (122), Pp 
= 20, Pout = 2 
5.9 
 
59.8 
 
6 
(94) 
56.7 
(94) 
Dog 
small 
intestine 
Control 
RL = 34 (91), Kf = 0.37 (79), 
Pc = 10 (79), Cc = 60 (94), σ = 
0.7 (122), PS = 0.09 (60), Pp 
= 20, Pout = 2 
-0.6 
 
24.4 
 
0 
(80) 
- 
 
Sheep 
lung 
Base 
line 
RL = 100 (93), Kf = 0.014 
(45), Pc = 14.34 (45), Cc = 74 
(45), σ = 0.48 (122), PS = 
0.02 (122), Pp = 20, Pout = 2 
-2.4 
 
42.5 
 
- 
 
44.7 
(45) 
 
B 
Animal 
model 
Inter-
vention 
Values of other parameters Kf = 0.07 Kf = 0.11 
Pi Ci Pi Ci 
Dog lung Control 
RL = 76 (37), Pc = 7 (52), Cc = 
58 (74), σ = 0.62 (122), PS = 
0.07 (122), Pp = 20, Pout = 2 
-2.2 
 
31 
 
-1.3 
 
30.7 
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Table B-1 continued. 
 
C 
Animal 
model 
Inter-
vention 
Values of other parameters σ = 0.48 σ = 0.89 
Pi Ci Pi Ci 
Dog lung Control 
RL = 76 (37), Kf = 0.07 (43, 
68), Pc = 7 (52), Cc = 58 (74), 
PS = 0.07 (122), Pp = 20, Pout 
= 2 
-0.2 
 
36.6 
 
-6.7 
 
22.9 
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Table B-2:  The range of parameter values affecting Edemagenic Gain, estimated 
from previously published reports. Kf : microvascular filtration coefficient; RL : effective 
lymphatic resistance; C : interstitial compliance. 
 
 
 
Ref. # Animal Model Intervention RL (cmH2O·min/μl)
(93) Sheep lung 
Control 0.54 ± 0.47 
Left atrial pressure elevation 0.24 ± 0.3 
(39) Canine lung 
Extrapulmonary vessel 0.042 ± 0.03 
Intrapulmonary vessel 0.026 ± 0.02 
Ref. # Animal Model Intervention Kf (ml/min·mmHg·100g) 
(68) Canine lung Left atrial pressure elevation 0.07 
(98) Canine lung Left atrial pressure elevation 0.08 
(41) Canine lung Pulmonary arterial and venous pressure elevation 0.11 ± 0.06 
(43) Canine lung Pulmonary venous pressure elevation 0.07 ± 0.01 
(149) Rabbit lung Pulmonary arterial pressure elevation 1.0 
(52) Canine lung Pulmonary arterial and venous pressure elevation 0.07 ± 0.01 
(35) Canine lung Pulmonary arterial and venous pressure elevation 0.21 ± 0.09 
(58) Canine lung Transpulmonary pressure elevation 
0.042 ± 0.02 
0.037 ± 0.011 
Ref. # Animal Model Intervention C (ml/g·mmHg) 
(58) Canine lung Transpulmonary pressure elevation 0.137 ± 0.094 
(102) Rabbit lung 
Control 0.019 
Pulmonary arterial and venous 
pressure elevation 0.025 
(121) Canine lung 
Control 0.042 
Pulmonary arterial pressure 
elevation 0.565 
(112) Rabbit lung Pulmonary arterial and venous pressure elevation 0.005 
(114) Canine lung Transpulmonary pressure elevation 0.024 
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Table B-3: Sensitivity of Edemagenic Gain (EG) to various parameters. Kf : 
microvascular filtration coefficient; RL : effective lymphatic resistance; C : interstitial 
compliance. 
 
 
When 1<<⋅ fL KR  
Parameter Change in parameter Change in EG 
C  100% 100% 
LR  100% ≈ 95% 
fK  100% ≈ 95% 
 
 
When 1=⋅ fL KR  
Parameter Change in parameter Change in EG 
C  100% 100% 
LR  100% ≈ 50% 
fK  100% ≈ 50% 
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APPENDIX C 
 
Nonlinear forms of the protein extravasation equation. Based on the principles of 
irreversible thermodynamics, Kedem and Katchalsky characterized solute transport 
across homoporous, sieving membranes (Eq. C1) (84). In this formulation, the 
convective and diffusive processes responsible for protein extravasation are considered 
independent of each other. On the other hand, the Patlak-Hoffman formulation (Eq. C2) 
(123) considers simultaneous convection and diffusion of proteins through the same 
pathway. In fact, their formulation generalizes the Hertzian formulation for sieving 
membranes, recognized as the gold standard for non-sieving membranes (18). The 
Manning formulation (Eq. C3) (103) is a linear approximation of Patlak-Hoffman 
formulation, assuming small JV. The Taylor-Granger formulation (Eq. 3.3) (147) is the 
linear empirical approximation of Kedem-Katchalsky formulation. Except for the 
Kedem-Katchalsky formulation, the two-well accepted formulations (Eqs. C2 and C3), 
along with Taylor-Granger formulation, suggest that CL/Cc approaches (1-σ) with 
increasing JV, i.e., lymph protein concentration (CL) approaches a constant value at high 
JV. 
( )(1 ) ( )
ln
KK c i
sV V c i
c
i
C CJ J C C PSC
C
σ −= − + −  
(C1)
(1 )
(1 )
(1 )( )
1
V
V
J
PS
PH V c i
sV J
PS
J e C CJ
e
σ
σ
σ
−
−
− −=
−
 (C2)
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(1 ) ( )
2
M c i
sV V c i
C CJ J C C PSσ += − + −  (C3)
Comparison of numerical solutions for protein extravasation. Various 
comparative studies have reported the accuracy of different microvascular protein 
extravasation characterizations. One such study by Breseler et al. (18) compared the 
Kedem-Katchlasky and Manning formulations to the Patlak-Hoffman formulation. The 
Taylor-Granger formulation (147) has not been included in such studies. In the present 
work, an approach similar to that of Breseler et al. was used to compare the accuracy of 
the JsV estimation by the Taylor-Granger formulation (Eq. 3.3) with those of Kedem-
Katchlasky (Eq. C1), Patlak-Hoffman (Eq. C2), and Manning (Eq. C3). As reported by 
Breseler et al. (18), the Patlak-Hoffman formulation is considered as the gold standard 
for comparison purposes. The ratio of errors in JsV estimation is determined with Eqs. 
C4a and C4b. Equation C4a compares the Taylor-Granger formulation with the Kedem-
Katchlasky formulation, and Eq. C4b compares the Taylor-Granger formulation with the 
Manning formulation.  
1
PH KK
sV sV
PH TG
sV sV
J J
R
J J
−= −  R1 > 1; Eq. 3.4 better approximates Eq. C1 (C4a)
2
PH M
sV sV
PH TG
sV sV
J J
R
J J
−= −  R2 >1; Eq. 3.4 better approximates Eq. C1 (C4b)
Figure A-5A illustrates R1 as a function of JV with Ci/Cc = 0.1, 0.5 and 0.9 (σ = 0.6, PS 
= 0.118). Figure A-5B illustrates R2 as a function of JV with Ci/Cc = 0.1, 0.5 and 0.9 (σ = 
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0.6, PS = 0.118). The Taylor-Granger formulation better approximates the Patlak-
Hoffman formulation with increasing JV than the others. 
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APPENDIX D 
 
Derivation of Edemagenic Gain. In this formulation, interstitial hydrostatic 
pressure (Pi), microvascular fluid filtration (JV), and lymphatic outflow (JL) are 
considered to be functions of interstitial fluid volume. The microvascular reflection 
coefficient (σ) is considered to be constant, and the effect of changes in microvascular 
filtration on interstitial colloid osmotic pressure is neglected. A piecewise linear 
relationship between interstitial hydrostatic pressure and interstitial fluid volume is 
assumed (Eq. 4.1). Interstitial compliance, reciprocal of the slope of this relationship, 
determines the effect of change in interstitial fluid volume on interstitial hydrostatic 
pressure. Substituting this relationship (Eq. 4.1) into the Starling-Landis Equation (Eq. 
3.1), indicates how transmicrovascular flow is affected by changes in interstitial fluid 
volume.  
( )V f c o c iVJ K P P C σ
⎡ ⎤⎛ ⎞= ⋅ − − − ⋅ Π − Π⎜ ⎟⎢ ⎥⎝ ⎠⎣ ⎦   
                                                                   (D1) 
By substituting Eq. D1 and the Drake-Laine Model (Eq. 3.4) into Eq. 4.2, the effect of 
changes in interstitial fluid volume on lymphatic flow can be reformulated into an 
integral, 
( ) o outf c o c i initial
L
VP P
V CV K P P dt V
C R
σ
⎛ ⎞⎛ ⎞+ −⎜ ⎟⎜ ⎟⎡ ⎤⎛ ⎞ ⎝ ⎠⎜ ⎟= ⋅ − − − ⋅ Π − Π − ⋅ +⎜ ⎟⎢ ⎥⎜ ⎟⎝ ⎠⎣ ⎦⎜ ⎟⎝ ⎠
∫                      (D2) 
where Vinitial is the initial volume.  
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Integrating Eq. D2 results in interstitial fluid volume as an analytical equation 
that includes a function of time (t).  
( ) ( ) ( )
1 1
L f
c o c i o out
L f L f
C R K CV P P P P
R K R K
σ⋅ ⋅ ⎡ ⎤= ⋅ − − ⋅ Π − Π − ⋅ −⎣ ⎦+ ⋅ + ⋅
1
exp
1
L fL
initial
L f L
R KC R t V
R K C R
⎡ ⎤+ ⋅⎛ ⎞⋅− ⋅ − ⋅ +⎢ ⎥⎜ ⎟+ ⋅ ⋅⎝ ⎠⎣ ⎦
    (D3) 
Assuming all parameters are constant, the difference between two volumes is obtained as 
a result of changes in effective microvascular driving pressure (Pc-σ ·Πc) and expressed 
as “Edemagenic Gain” (Eq. 4.3) 
 In previous attempts to characterize the change in interstitial fluid volume in 
response to change in the effective microvascular driving pressure (53), interstitial 
hydrostatic pressure was considered constant. The negative feedback provided by 
changes in interstitial hydrostatic pressure, therefore, was neglected. The change in 
interstitial fluid volume given by the time integral of the inflow and outflow rate (Eq. 
4.2) would thus be 
( )( ) ( )f c i c i L initialV K P P J t Vσ⎡ ⎤= ⋅ − − ⋅ Π − Π − ⋅ +⎣ ⎦                                                        (D4) 
The relation between change in interstitial fluid volume and change in effective 
microvascular driving pressure is obtained from Eq. D4. 
( ) fc c
V K t
P σ
Δ = ⋅Δ − ⋅Π                                                                                                   (D5) 
The formulation of Edemagenic Gain presented in the current work (Eq. 4.3) is preferred 
over Eq. D5, because Eq. 4.3 does not require the assumption that interstitial hydrostatic 
pressure is constant, and thus it requires fewer assumptions.  
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 The formulation of Edemagenic Gain represented by Eq. 4.3 can be modified to 
characterize the relationship of ΔV to changes in the microvascular driving pressure 
determined by Pc, Πc, Πi, and σ. The modified Edemagenic Gain thus becomes a 
function of the microvascular reflection coefficient,  as well as interstitial colloid 
osmotic pressure Πi. 
( ( )) 1
L f
c c i L f
C R KVEG
P R Kσ
⋅ ⋅Δ= =Δ − ⋅ Π − Π + ⋅                               (D6) 
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